review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1152/PHYSREV.00043.2008 |
P8608 | Fatcat ID | release_l7ox3i7ldjdujl7bbjkwvgfx3y |
P932 | PMC publication ID | 3970937 |
P698 | PubMed publication ID | 20086074 |
P5875 | ResearchGate publication ID | 41088175 |
P50 | author | Jerome Dempsey | Q29653442 |
P2093 | author name string | Barbara J Morgan | |
Christopher P O'Donnell | |||
Sigrid C Veasey | |||
P2860 | cites work | Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury | Q21144702 |
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index | Q21144740 | ||
Impact of sleep debt on metabolic and endocrine function | Q23731787 | ||
Blood pressure associated with sleep-disordered breathing in a population sample of children | Q24605368 | ||
Angiogenesis in cancer and other diseases | Q27861015 | ||
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta | Q28188643 | ||
DISTRIBUTION OF BLOOD FLOW IN ISOLATED LUNG; RELATION TO VASCULAR AND ALVEOLAR PRESSURES | Q28198229 | ||
Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients | Q28267419 | ||
Modulation of hypoglossal motoneuron excitability by NK1 receptor activation in neonatal mice in vitro | Q28344027 | ||
Cerebral metabolic impairment in patients with obstructive sleep apnoea: an independent association of obstructive sleep apnoea with white matter change | Q28346304 | ||
Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension | Q28570889 | ||
Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain | Q28572076 | ||
Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body | Q28577913 | ||
Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity | Q28578154 | ||
Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia | Q28588503 | ||
The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite | Q29615447 | ||
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study | Q29615583 | ||
Leptin and the regulation of body weight in mammals | Q29615976 | ||
Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial | Q46662974 | ||
Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). | Q46664744 | ||
Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure | Q46684398 | ||
Central sleep apnea in stable methadone maintenance treatment patients | Q46703250 | ||
Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress | Q46713753 | ||
Eif-2a protects brainstem motoneurons in a murine model of sleep apnea | Q46729669 | ||
Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome. | Q46732694 | ||
Electrocardiographically indicated cardiovascular disease in sleep-disordered breathing | Q46774096 | ||
Continuous positive airway pressure for central sleep apnea and heart failure | Q46799634 | ||
Opiate slowing of feline respiratory rhythm and effects on putative medullary phase-regulating neurons | Q46801049 | ||
Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. | Q46801934 | ||
Positron emission tomography findings in obstructive sleep apnea patients with residual sleepiness treated with continuous positive airway pressure. | Q46802024 | ||
The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. | Q46817068 | ||
Serotoninergic receptors in the anteroventral preoptic region modulate the hypoxic ventilatory response | Q46822411 | ||
Activation and desensitization of neuronal nicotinic receptors modulate glutamatergic transmission on neonatal rat hypoglossal motoneurons | Q46832677 | ||
Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries | Q46853084 | ||
Noradrenergic, serotonergic and GABAergic antagonists injected together into the XII nucleus abolish the REM sleep-like depression of hypoglossal motoneuronal activity | Q46858431 | ||
Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study | Q46960378 | ||
Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome | Q46965619 | ||
Atomoxetine improves sleepiness and global severity of illness but not the respiratory disturbance index in mild to moderate obstructive sleep apnea with sleepiness | Q46977506 | ||
Pharyngeal size and shape during wakefulness and sleep in patients with obstructive sleep apnoea | Q47172024 | ||
Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea | Q47203231 | ||
Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia | Q47251020 | ||
Recent weight gain in patients with newly diagnosed obstructive sleep apnea | Q47257483 | ||
The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? | Q47288086 | ||
Relationship between adipocyte size and adipokine expression and secretion | Q47310274 | ||
Excess weight and sleep-disordered breathing | Q47368959 | ||
The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation | Q47405338 | ||
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea | Q47425576 | ||
Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea | Q47446409 | ||
Upper airway muscle inflammation and denervation changes in obstructive sleep apnea | Q47582296 | ||
Ontogeny of postnatal hyoid and larynx descent in humans | Q47643615 | ||
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients | Q47644015 | ||
Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration | Q47663430 | ||
Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders | Q47692638 | ||
The ontogeny of cranial base angulation in humans and chimpanzees and its implications for reconstructing pharyngeal dimensions | Q47719815 | ||
Influence of arterial O2 on the susceptibility to posthyperventilation apnea during sleep | Q47723312 | ||
Surface tension of upper airway mucosal lining liquid in obstructive sleep apnea/hypopnea syndrome | Q47725470 | ||
Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. | Q47725503 | ||
Response time and sensitivity of the ventilatory response to CO2 in unanesthetized intact dogs: central vs. peripheral chemoreceptors | Q47726910 | ||
Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure | Q47742694 | ||
Ventilation is unstable during drowsiness before sleep onset | Q47762439 | ||
Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice | Q47767899 | ||
Cerebrovascular response to carbon dioxide in patients with congestive heart failure | Q47794875 | ||
Down regulation of Kv3.4 channels by chronic hypoxia increases acute oxygen sensitivity in rabbit carotid body. | Q47797805 | ||
Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome | Q47801435 | ||
Craniofacial morphology, head posture, and nasal respiratory resistance in obstructive sleep apnoea: an inter-ethnic comparison | Q47839551 | ||
Cerebral structural changes in severe obstructive sleep apnea | Q47852334 | ||
Functional imaging of working memory in obstructive sleep-disordered breathing | Q47858547 | ||
Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome | Q47869968 | ||
The Great Leap Forward: the anatomic basis for the acquisition of speech and obstructive sleep apnea | Q35573209 | ||
Serotonin receptors: guardians of stable breathing | Q35601739 | ||
Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). | Q35602313 | ||
Mesopontine cholinergic projections to the hypoglossal motor nucleus | Q35754242 | ||
Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
Oxidative stress in the systemic and cellular responses to intermittent hypoxia | Q35768167 | ||
Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas | Q35812078 | ||
Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome | Q35821094 | ||
The ventilatory responsiveness to CO(2) below eupnoea as a determinant of ventilatory stability in sleep. | Q35850899 | ||
Cerebral ischemia and the unfolded protein response | Q35893250 | ||
Pontine cholinergic mechanisms and their impact on respiratory regulation | Q35935553 | ||
Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing | Q35995385 | ||
Association between metabolic syndrome and sleep-disordered breathing in adolescents | Q36013648 | ||
Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions | Q36107869 | ||
Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. | Q36107883 | ||
NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits | Q36114032 | ||
Load compensation and respiratory muscle function during sleep | Q36145898 | ||
Reduced cerebral blood flow during wakefulness in obstructive sleep apnea-hypopnea syndrome | Q36151492 | ||
Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation | Q36203132 | ||
Impact of obstructive apnea syndrome on upper airway respiratory muscles | Q36212835 | ||
Cellular and molecular mechanisms associated with carotid body adaptations to chronic hypoxia | Q36214817 | ||
Influence of wakefulness on pharyngeal airway muscle activity | Q36225941 | ||
Treatment for obstructive sleep apnoea: effect on peripheral nerve function | Q36226886 | ||
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
Shared genetic risk factors for obstructive sleep apnea and obesity. | Q36256296 | ||
Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. | Q36276576 | ||
Recognition and management of complex sleep-disordered breathing | Q36282909 | ||
Chronic intermittent hypoxia induces atherosclerosis | Q36330538 | ||
Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. | Q36383244 | ||
Respiratory control stability and upper airway collapsibility in men and women with obstructive sleep apnea | Q36395020 | ||
The impact of anatomic manipulations on pharyngeal collapse: results from a computational model of the normal human upper airway | Q36405705 | ||
Genioglossal muscle response to CO2 stimulation during NREM sleep | Q36405724 | ||
Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain | Q36419743 | ||
Prolonged expiratory phase in sleep apnea. A unifying hypothesis | Q41485407 | ||
Changes in serotonin level in the hypoglossal nucleus region during carbachol-induced atonia. | Q41662617 | ||
A neuromuscular mechanism maintaining extrathoracic airway patency | Q41686091 | ||
Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea | Q41711461 | ||
Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity | Q41738835 | ||
Effects of graded reduction of brain blood flow on ventilation in unanesthetized goats | Q41738968 | ||
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia | Q41980368 | ||
NFATc3 is required for intermittent hypoxia-induced hypertension | Q42410702 | ||
Medial and endothelial platelet-derived growth factor A chain expression is regulated by in vivo exposure to elevated flow | Q42465571 | ||
Renin activity and blood pressure in response to chronic episodic hypoxia | Q42476427 | ||
Differential role of the paraventricular nucleus of the hypothalamus in modulating the sympathoexcitatory component of peripheral and central chemoreflexes | Q42478844 | ||
Cellular mechanisms involved in rabbit carotid body excitation elicited by endothelin peptides | Q42489186 | ||
A putative flip-flop switch for control of REM sleep | Q42495172 | ||
Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy | Q42512473 | ||
Release of hypocretin (orexin) during waking and sleep states. | Q42523162 | ||
Role of inhibitory amino acids in control of hypoglossal motor outflow to genioglossus muscle in naturally sleeping rats | Q42606852 | ||
GABAA receptor antagonism at the hypoglossal motor nucleus increases genioglossus muscle activity in NREM but not REM sleep | Q42695631 | ||
Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity | Q42738504 | ||
Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes | Q42764571 | ||
Influence of obstructive sleep apnea on mortality in patients with heart failure | Q43433552 | ||
Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome | Q43456634 | ||
Inhibition of inspiratory upper airway motoneuron activity by phasic volume feedback | Q43501437 | ||
The effects of ondansetron on sleep-disordered breathing in the English bulldog. | Q43541342 | ||
Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. | Q43545269 | ||
Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep | Q43570681 | ||
Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats | Q43572857 | ||
Effect of Clonidine in Obstructive Sleep Apnea | Q43582833 | ||
Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance | Q43584172 | ||
Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects | Q43651825 | ||
Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up | Q43715275 | ||
Alpha(1B) receptors are the main postsynaptic mediators of adrenergic excitation in brainstem motoneurons, a single-cell RT-PCR study | Q43719691 | ||
The motor inhibitory system operating during active sleep is tonically suppressed by GABAergic mechanisms during other states | Q43766622 | ||
Evidence for lipid peroxidation in obstructive sleep apnea | Q43800410 | ||
Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. | Q43854250 | ||
Systemic and local adrenergic regulation of muscle glucose utilization during hypoglycemia in healthy subjects | Q43901616 | ||
Obstructive sleep apnea is independently associated with insulin resistance. | Q43903080 | ||
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. | Q43903083 | ||
Modulation of phrenic motoneuron excitability by ATP: consequences for respiratory-related output in vitro. | Q43964415 | ||
Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. | Q43980951 | ||
A locally generated angiotensin system in rat carotid body. | Q44077189 | ||
Afferent pathway(s) for pharyngeal dilator reflex to negative pressure in man: a study using upper airway anaesthesia | Q44108678 | ||
Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. | Q44117488 | ||
Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. | Q44147029 | ||
Brain morphology associated with obstructive sleep apnea | Q44159112 | ||
Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies | Q44161155 | ||
Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk | Q44168768 | ||
Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome | Q44178011 | ||
Nicotinic excitation of rat hypoglossal motoneurons | Q44219024 | ||
Suppression of genioglossus muscle tone and activity during reflex hypercapnic stimulation by GABA(A) mechanisms at the hypoglossal motor nucleus in vivo | Q44283579 | ||
A prospective study of self-reported sleep duration and incident diabetes in women | Q44291206 | ||
Longitudinal study of moderate weight change and sleep-disordered breathing | Q44313768 | ||
Mechanisms of the cerebrovascular response to apnoea in humans | Q44317043 | ||
The English bulldog: a natural model of sleep-disordered breathing | Q44321964 | ||
Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism | Q44336714 | ||
Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. | Q44349360 | ||
Effect of Acetazolamide on Hypoxemia during Sleep at High Altitude | Q44383344 | ||
Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea | Q44387214 | ||
Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial | Q44445146 | ||
Clinical effects of locally delivered nicotine in obstructive sleep apnea syndrome | Q44447296 | ||
Alveolar hypoventilation syndrome. Studies of ventilatory control in patients selected for diaphragm pacing | Q44470873 | ||
Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern--a recognizable polysomnographic variant with practical clinical implications | Q44508613 | ||
Intermittent hypoxia increases insulin resistance in genetically obese mice | Q44524266 | ||
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations | Q44554087 | ||
Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension | Q44573309 | ||
Reduction of sleep-disordered breathing after physostigmine | Q44575158 | ||
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure | Q44578930 | ||
Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance | Q44584057 | ||
Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. | Q44598192 | ||
Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries | Q44598223 | ||
Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea | Q44612095 | ||
8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. | Q44615125 | ||
The modulation by 5-HT of glutamatergic inputs from the raphe pallidus to rat hypoglossal motoneurones, in vitro | Q44615235 | ||
Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure | Q44641932 | ||
5-HT at hypoglossal motor nucleus and respiratory control of genioglossus muscle in anesthetized rats | Q44650019 | ||
Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways. | Q44662113 | ||
Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species | Q44680894 | ||
Oxidative stress in severe pulmonary hypertension | Q44710488 | ||
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients | Q44773562 | ||
Oxidative injury to the endoplasmic reticulum in mouse brains after transient focal ischemia | Q44790375 | ||
Inhibition of Insulin Release by Norepinephrine in Man | Q44804200 | ||
Hypoxia causes glucose intolerance in humans. | Q44814411 | ||
Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions | Q44881796 | ||
Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study | Q45048798 | ||
Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist | Q45050579 | ||
Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension | Q45062680 | ||
Pre- and postsynaptic modulation of glycinergic and gabaergic transmission by muscarinic receptors on rat hypoglossal motoneurons in vitro | Q45181896 | ||
Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver | Q45197559 | ||
Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. | Q45214773 | ||
Damage to the endoplasmic reticulum and activation of apoptotic machinery by oxidative stress in ischemic neurons | Q45242538 | ||
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study | Q45304416 | ||
Snoring as a risk factor for type II diabetes mellitus: a prospective study | Q45305411 | ||
The effect of hypoxia on baroreflexes and pressor sensitivity in sleep apnea and hypertension | Q46306844 | ||
Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo | Q46427662 | ||
Dynamics of periodic breathing and arousal during sleep at extreme altitude | Q46440183 | ||
Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea | Q46460378 | ||
Medullary serotonergic neurones modulate the ventilatory response to hypercapnia, but not hypoxia in conscious rats | Q46477266 | ||
Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome | Q46484855 | ||
Neurotransmitter phenotypes of intermediate zone reticular formation projections to the motor trigeminal and hypoglossal nuclei in the rat. | Q46506326 | ||
CHOP plays a pivotal role in the astrocyte death induced by oxygen and glucose deprivation | Q46587446 | ||
Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats | Q46601745 | ||
Crossing the apnoeic threshold: causes and consequences | Q47887447 | ||
An investigation into the relationship between the severity of obstructive sleep apnoea/hypopnoea syndrome and the vertical position of the hyoid bone | Q47887787 | ||
Cardiorespiratory function in stable methadone maintenance treatment (MMT) patients | Q47904697 | ||
Respiratory responses to intermittent hypoxia in unsedated piglets: relation to substance P binding in brainstem | Q47913988 | ||
Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging | Q47914137 | ||
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation | Q47918768 | ||
Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial | Q47920342 | ||
Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity | Q47955291 | ||
Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing | Q48022686 | ||
A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences | Q48032564 | ||
Linkage between brain blood flow and respiratory drive during rapid-eye-movement sleep | Q48090991 | ||
Interaction between chemoreceptor and stretch receptor inputs at medullary respiratory neurons | Q48112969 | ||
CO(2) microdialysis in retrotrapezoid nucleus of the rat increases breathing in wakefulness but not in sleep | Q48114282 | ||
Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). | Q48125932 | ||
Microdialysis delivery of morphine to the hypoglossal nucleus of Wistar rat increases hypoglossal acetylcholine release | Q48145376 | ||
Changes in brain morphology associated with obstructive sleep apnea | Q48157373 | ||
Substance P-immunoreactive boutons closely appose inspiratory protruder hypoglossal motoneurons in the cat. | Q48162363 | ||
The apneic threshold during non-REM sleep in dogs: sensitivity of carotid body vs. central chemoreceptors | Q48171557 | ||
Silent brain infarction and platelet activation in obstructive sleep apnea | Q48251845 | ||
Reactivity of cerebral blood flow to carbon dioxide in various types of ischemic cerebrovascular disease: evaluation by the transcranial Doppler method | Q48290664 | ||
Effects of specific carotid body and brain hypoxia on respiratory muscle control in the awake goat | Q48351953 | ||
The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling | Q48412192 | ||
A negative interaction between brainstem and peripheral respiratory chemoreceptors modulates peripheral chemoreflex magnitude. | Q48414961 | ||
Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. | Q48418702 | ||
Behavior of VRG neurons during the atonia of REM sleep induced by pontine carbachol in decerebrate cats | Q48420693 | ||
Assessment of intracranial hemodynamics in sleep apnea syndrome | Q48425286 | ||
Lower body positive pressure increases upper airway collapsibility in healthy subjects | Q48436635 | ||
Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy humans | Q48437765 | ||
Activity of respiratory neurons during NREM sleep | Q48437961 | ||
Masked hypertension in obstructive sleep apnea syndrome | Q48438013 | ||
Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP. | Q48440095 | ||
Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome | Q48448229 | ||
Nocturnal cardiac arrhythmia in patients with obstructive sleep apnea. | Q48450974 | ||
Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia | Q48451162 | ||
Chronic intermittent hypoxia increases the CO2 reserve in sleeping dogs | Q48454461 | ||
Severe sleep apnea and risk of ischemic stroke in the elderly. | Q48455002 | ||
Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome | Q48455753 | ||
C-reactive protein and fibrinogen in acute stroke patients with and without sleep apnea | Q48456610 | ||
Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. | Q48457049 | ||
Mechanisms of breathing instability in patients with obstructive sleep apnea | Q48457747 | ||
Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release | Q48463382 | ||
Lung volume and collapsibility of the passive pharynx in patients with sleep-disordered breathing | Q48463593 | ||
Effect of genioglossus contraction on pharyngeal lumen and airflow in sleep apnoea patients | Q48464724 | ||
CPAP should not be used for central sleep apnea in congestive heart failure patients. | Q48466090 | ||
Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea | Q48466428 | ||
The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension | Q48468115 | ||
Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling | Q48469363 | ||
Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea | Q48469918 | ||
Chronic intermittent hypoxia predisposes to liver injury | Q48473495 | ||
Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension | Q48474993 | ||
Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome | Q48620431 | ||
Relationship between surface tension of upper airway lining liquid and upper airway collapsibility during sleep in obstructive sleep apnea hypopnea syndrome | Q48623276 | ||
Cardiorespiratory Effects of Added Dead Space in Patients With Heart Failure and Central Sleep Apnea | Q48628760 | ||
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure | Q48634373 | ||
Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study | Q48634392 | ||
Pembrey's dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure | Q48636625 | ||
P2 receptor excitation of rodent hypoglossal motoneuron activity in vitro and in vivo: a molecular physiological analysis. | Q48637309 | ||
Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea | Q48640268 | ||
Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. | Q48641801 | ||
Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome | Q48643754 | ||
The male predisposition to pharyngeal collapse: importance of airway length | Q48646084 | ||
Carotid body denervation eliminates apnea in response to transient hypocapnia | Q48648039 | ||
Prolonged surges of baroreflex-resistant muscle sympathetic drive during periodic breathing. | Q48650285 | ||
Modulation of upper airway collapsibility during sleep: influence of respiratory phase and flow regimen. | Q48650682 | ||
Anatomic determinants of sleep-disordered breathing across the spectrum of clinical and nonclinical male subjects | Q48651079 | ||
Effect of surfactant on pharyngeal mechanics in sleeping humans: implications for sleep apnoea | Q48652008 | ||
Brain angiotensin II: new insights into its role in sympathetic regulation | Q48652656 | ||
Elevated C-reactive protein in patients with obstructive sleep apnea | Q48660954 | ||
Apnea-hypopnea threshold for CO2 in patients with congestive heart failure | Q48663138 | ||
Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study | Q48664229 | ||
Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis | Q48665802 | ||
The effect of neuromuscular stimulation of the genioglossus on the hypopharyngeal airway | Q48667721 | ||
Improvement in neuropsychological performance following surgical treatment for obstructive sleep apnea syndrome | Q48668327 | ||
Inattention, hyperactivity, and symptoms of sleep-disordered breathing | Q48668369 | ||
Abnormal palatopharyngeal muscle morphology in sleep-disordered breathing | Q48669225 | ||
Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction | Q48670679 | ||
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial | Q48672164 | ||
Effects of sleep-wake state on the genioglossus vs.diaphragm muscle response to CO(2) in rats | Q48673020 | ||
Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system | Q48673050 | ||
Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep-disordered breathing | Q48673227 | ||
Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics | Q48673471 | ||
Obstructive apnea during sleep is associated with peripheral vasoconstriction | Q48673756 | ||
Sleep-disordered breathing and coronary artery disease: long-term prognosis | Q48677504 | ||
Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure | Q48684878 | ||
Effect of hypoxia on the hypopnoeic and apnoeic threshold for CO(2) in sleeping humans | Q48685460 | ||
Impact of obstructive sleep apnea on left ventricular mass and diastolic function | Q48691685 | ||
Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial | Q48692215 | ||
Nonchemical elimination of inspiratory motor output via mechanical ventilation in sleep | Q48693572 | ||
Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia | Q48694134 | ||
CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. | Q48696352 | ||
Magnetic resonance imaging of the pharynx in OSA patients and healthy subjects | Q48696514 | ||
Blood pressure perturbations caused by subclinical sleep-disordered breathing | Q48697545 | ||
Role of endothelin in intermittent hypoxia-induced hypertension | Q48701728 | ||
Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay | Q48704758 | ||
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 | ||
Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome | Q48705061 | ||
Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. | Q48708402 | ||
Fibrinogen levels and obstructive sleep apnea in ischemic stroke | Q48708426 | ||
Platelet function in patients with obstructive sleep apnoea syndrome | Q48708646 | ||
Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea | Q48709586 | ||
5-HT2 receptors. | Q30339012 | ||
The emerging epidemic of obesity in developing countries. | Q30352086 | ||
The 2008 Carl Ludwig Lecture: retrotrapezoid nucleus, CO2 homeostasis, and breathing automaticity | Q30439053 | ||
Peripheral chemoreceptor inputs to retrotrapezoid nucleus (RTN) CO2-sensitive neurons in rats | Q30439417 | ||
Expression of Phox2b by brainstem neurons involved in chemosensory integration in the adult rat. | Q30441790 | ||
Upper Airway Muscle Activation Is Augmented in Patients with Obstructive Sleep Apnea Compared with That in Normal Subjects | Q30462513 | ||
Pharyngeal fat in obstructive sleep apnea | Q30467139 | ||
Time-dependent adaptation in the hemodynamic response to hypoxia. | Q30484430 | ||
Altered upper airway and soft tissue structures in the New Zealand Obese mouse | Q30485689 | ||
Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea | Q30489999 | ||
Cerebrovascular response to arousal from NREM and REM sleep. | Q30493611 | ||
Pharyngeal shape and dimensions in healthy subjects, snorers, and patients with obstructive sleep apnoea | Q30496440 | ||
Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model | Q30500690 | ||
Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials | Q30954736 | ||
Fos expression in orexin neurons varies with behavioral state. | Q32062017 | ||
Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy | Q33145749 | ||
Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. | Q33181809 | ||
Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms | Q33267996 | ||
Ventilatory control and airway anatomy in obstructive sleep apnea | Q33432033 | ||
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure | Q33471794 | ||
Static mechanics of the velopharynx of patients with obstructive sleep apnea | Q33485260 | ||
Effects of sleep fragmentation on glucose metabolism in normal subjects | Q33577379 | ||
"Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease | Q33588198 | ||
Adult obstructive sleep apnea: pathophysiology and diagnosis | Q33619089 | ||
NO and CO as second messengers in oxygen sensing in the carotid body | Q33672137 | ||
Independent association between obstructive sleep apnea and subclinical coronary artery disease | Q33700621 | ||
Role of peripheral serotonin in the regulation of central sleep apneas in rats | Q33862626 | ||
Prognostic value of ambulatory blood pressure : current evidence and clinical implications | Q33864724 | ||
Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes | Q33896005 | ||
Extreme obesity associated with alveolar hypoventilation; a Pickwickian syndrome | Q33969326 | ||
Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. | Q34017531 | ||
Determinants of ventilatory instability and variability | Q34020046 | ||
Multiple sites for central chemoreception: their roles in response sensitivity and in sleep and wakefulness | Q34020071 | ||
The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control | Q36598776 | ||
Obesity and obstructive sleep apnea in children | Q36650911 | ||
Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children | Q36657681 | ||
Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas | Q36657686 | ||
Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension | Q36662356 | ||
Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy | Q36667880 | ||
Histological and ultrastructural localization of the kainate receptor subunits, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies | Q36715590 | ||
ER stress and diseases. | Q36731474 | ||
Contribution of male sex, age, and obesity to mechanical instability of the upper airway during sleep | Q36776107 | ||
Brain structural changes in obstructive sleep apnea | Q36800544 | ||
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia | Q36807926 | ||
Childhood overweight, obesity, and the metabolic syndrome in developing countries | Q36810809 | ||
Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure | Q36817015 | ||
Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains | Q36846751 | ||
Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress | Q36849018 | ||
Neurocognitive and behavioral morbidity in children with sleep disorders | Q36954283 | ||
Aldosterone and vascular inflammation | Q37048931 | ||
Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches | Q37077157 | ||
Central sleep apnea and Cheyne-Stokes respiration | Q37077168 | ||
Influence of cerebral blood flow on breathing stability | Q37139015 | ||
Some aspects of clinical relevance in the maturation of respiratory control in infants | Q37141660 | ||
Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study | Q37144291 | ||
Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers | Q37190183 | ||
A whole-genome scan for obstructive sleep apnea and obesity | Q37219579 | ||
Reactive oxygen species contribute to sleep apnea-induced hypertension in rats | Q37220930 | ||
Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study | Q37225106 | ||
Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders | Q37267023 | ||
Association of sleep-disordered breathing and the occurrence of stroke | Q37282690 | ||
Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea | Q37282714 | ||
Association of sleep apnea and type II diabetes: a population-based study | Q37282758 | ||
The influence of obstructive sleep apnea and gender on genioglossus activity during rapid eye movement sleep. | Q37424477 | ||
Impaired vascular regulation in patients with obstructive sleep apnea: effects of continuous positive airway pressure treatment | Q37443285 | ||
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link | Q37502404 | ||
Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression | Q37895578 | ||
Positive effect of CPAP treatment on the control of difficult-to-treat hypertension | Q48477044 | ||
Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction | Q48478550 | ||
Cardiovascular and metabolic effects of CPAP in obese males with OSA. | Q48479379 | ||
Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. | Q48480506 | ||
Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease | Q48481292 | ||
The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects | Q48483708 | ||
Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. | Q48483884 | ||
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia | Q48486252 | ||
Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome | Q48488274 | ||
Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea | Q48488578 | ||
Neuromechanical control of upper airway patency during sleep | Q48489322 | ||
Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects | Q48489723 | ||
Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states | Q48492029 | ||
Association between lipid peroxidation and inflammation in obstructive sleep apnoea | Q48494122 | ||
PHOX2B mutation-confirmed congenital central hypoventilation syndrome: presentation in adulthood | Q48494366 | ||
Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome | Q48495147 | ||
Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. | Q48497132 | ||
Changes in the activity of respiratory neurons during sleep | Q48497637 | ||
Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis | Q48499649 | ||
Effect of repetitive hypoxic apnoeas on baroreflex function in humans. | Q48500181 | ||
Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study | Q48500312 | ||
Evidence of impaired hypoxic vasodilation after intermediate-duration hypoxic exposure in humans | Q48502864 | ||
Increased propensity for apnea in response to acute elevations in left atrial pressure during sleep in the dog. | Q48504256 | ||
Plasma levels of vascular endothelial markers in obstructive sleep apnea | Q48504520 | ||
A role of pharyngeal length in obstructive sleep apnea patients | Q48506863 | ||
Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure | Q48507311 | ||
Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats | Q48512599 | ||
Upper airway function during sleep and wakefulness: experimental studies on normal and anesthetized cats. 1978 [classical article]. | Q48527421 | ||
Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome | Q48528105 | ||
Sex differences in blood pressure response to intermittent hypoxia in rats | Q48535302 | ||
Activation of a distinct arousal state immediately after spontaneous awakening from sleep | Q48536891 | ||
Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea | Q48538212 | ||
Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk | Q48544900 | ||
Hypoxic response of hypoglossal motoneurones in the in vivo cat. | Q48545058 | ||
Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats | Q48547568 | ||
Chronic liver injury during obstructive sleep apnea | Q48550777 | ||
Day-night pattern of sudden death in obstructive sleep apnea | Q48558148 | ||
Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome | Q48573657 | ||
Association of atrial fibrillation and obstructive sleep apnea | Q48587853 | ||
Contribution of endothelin-1 to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia | Q48593909 | ||
Peripheral 5-HT1A receptors are not essential for increased ventilation evoked by systemic 8-OH-DPAT challenge in anaesthetized rats. | Q48594766 | ||
Whole genome scan for obstructive sleep apnea and obesity in African-American families | Q48596650 | ||
Role of arousals in the pathogenesis of obstructive sleep apnea | Q48607323 | ||
The influence of lung volume on pharyngeal mechanics, collapsibility, and genioglossus muscle activation during sleep | Q48608984 | ||
Pulmonary hemodynamics in obstructive sleep apnea: frequency and causes of pulmonary hypertension | Q48615887 | ||
Upper airway surface tension: is it a significant cause of airflow obstruction during sleep? | Q48616607 | ||
Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 | ||
Sleep apnea and markers of vascular endothelial function in a large community sample of older adults | Q48616776 | ||
Effects of sleep state on ventilatory acclimatization to hypoxia in humans | Q48618089 | ||
Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea study | Q48619087 | ||
The placebo effect in heart failure | Q38000579 | ||
Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite | Q38295592 | ||
Intermittent hypoxia induces hyperlipidemia in lean mice. | Q38321740 | ||
Leptin attenuates respiratory complications associated with the obese phenotype | Q38330703 | ||
Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome | Q38361353 | ||
Sleep physiology at high altitude | Q39336577 | ||
Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea | Q39413535 | ||
Induction of periodic breathing during sleep causes upper airway obstruction in humans | Q39541605 | ||
Peripheral vascular resistance increases after termination of obstructive apneas | Q39583304 | ||
The effect of upper airway obstruction and arousal on peripheral arterial tonometry in obstructive sleep apnea | Q39632284 | ||
Unilateral ablation of pre-Botzinger complex disrupts breathing during sleep but not wakefulness. | Q39637483 | ||
Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea | Q39645233 | ||
Ambulatory blood pressure in children with obstructive sleep apnoea: a community based study | Q40106632 | ||
Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice | Q40151226 | ||
Waking and ventilatory responses to laryngeal stimulation in sleeping dogs | Q40198315 | ||
Brain stem gigantocellular neurons: patterns of activity during behavior and sleep in the freely moving rat | Q40218517 | ||
Respiratory neurons of the pneumotaxic center during sleep and wakefulness | Q40287122 | ||
Is obstructive sleep apnea a common cause of essential hypertension? | Q40413671 | ||
Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. | Q40628951 | ||
Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study | Q40699336 | ||
Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. | Q40704030 | ||
REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs | Q41065785 | ||
Correlation between oscillations in ventilation and frequency content of the electroencephalogram | Q41116400 | ||
Effects of pH on vascular tension: which are the important mechanisms? | Q41155753 | ||
The pharyngeal critical pressure. The whys and hows of using nasal continuous positive airway pressure diagnostically | Q41169490 | ||
The pulmonary circulation in cystic fibrosis | Q41193266 | ||
Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications | Q41204871 | ||
Upper airway occlusion during sleep in patients with Cheyne-Stokes respiration | Q41378669 | ||
Presynaptic inhibition by serotonin: a possible mechanism for switching motor output of the hypoglossal nucleus. | Q41403333 | ||
Excitatory drive to the respiratory system in REM sleep. | Q41403351 | ||
Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxia during sleep | Q41455172 | ||
Influence of reticular mechanisms upon hypoglossal, trigeminal and phrenic activities | Q41477112 | ||
Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease | Q41481128 | ||
Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares | Q34054705 | ||
Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans | Q34099337 | ||
Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients | Q34122262 | ||
Neonatal intermittent hypoxia impairs dopamine signaling and executive functioning. | Q34170090 | ||
Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy | Q34174067 | ||
Medullary serotonergic network deficiency in the sudden infant death syndrome: review of a 15-year study of a single dataset | Q34178799 | ||
Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling | Q34180887 | ||
Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. | Q34182043 | ||
Glucose clamp technique: a method for quantifying insulin secretion and resistance | Q34191986 | ||
Physiologic, metabolic, and muscle fiber type characteristics of musculus uvulae in sleep apnea hypopnea syndrome and in snorers | Q34192318 | ||
Extracellular matrix remodeling in the vascular wall | Q34294293 | ||
Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea | Q34327395 | ||
Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? | Q34341995 | ||
A double-blind, randomized trial of sabeluzole--a putative glutamate antagonist--in obstructive sleep apnea. | Q34394242 | ||
Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension | Q34415739 | ||
Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study | Q34461570 | ||
Obstructive sleep apnea as a risk factor for stroke and death | Q34466726 | ||
Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo | Q34504254 | ||
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study | Q34508280 | ||
Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits | Q34546476 | ||
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings | Q34562725 | ||
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp | Q34563818 | ||
Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms | Q34569861 | ||
Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation | Q34628531 | ||
L-tryptophan in the treatment of impaired respiration in sleep | Q34708766 | ||
Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments | Q34732249 | ||
Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study | Q34736623 | ||
Tonic activity in the respiratory system in wakefulness, NREM and REM sleep. | Q34768252 | ||
The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? | Q34996430 | ||
Hypoxic activation of adventitial fibroblasts: role in vascular remodeling | Q35022227 | ||
Characterization of the in vitro effects of 5-hydroxytryptamine (5-HT) on identified neurones of the rat dorsal motor nucleus of the vagus (DMV). | Q35041694 | ||
Role of oxidative stress in atherosclerosis | Q35088521 | ||
Effect of oxygen in obstructive sleep apnea: role of loop gain. | Q35095307 | ||
Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea | Q35139520 | ||
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment | Q48786336 | ||
State-related changes in upper airway caliber and surrounding soft-tissue structures in normal subjects | Q48786979 | ||
Instability of ventilatory control in patients with obstructive sleep apnea | Q48786991 | ||
Patterned cardiovascular responses to sleep and nonrespiratory arousals in a porcine model | Q48787353 | ||
Respiratory-related activity in hypoglossal neurons across sleep-waking states in cats | Q48793543 | ||
Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial | Q48799429 | ||
Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs | Q48801747 | ||
Ventilatory effects of specific carotid body hypocapnia in dogs during wakefulness and sleep | Q48805502 | ||
Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation | Q48806749 | ||
Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia | Q48809642 | ||
Effects of body position on the upper airway of patients with obstructive sleep apnea | Q48811689 | ||
Acute systemic blood pressure elevation in obstructive and nonobstructive breath hold in primates | Q48812069 | ||
Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans | Q48812084 | ||
Familial aggregates in obstructive sleep apnea syndrome. | Q48819246 | ||
Cardiac hypertrophy in obstructive sleep apnea syndrome | Q48819259 | ||
Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist | Q48820909 | ||
Effects of excitatory amino acid antagonists on the phasic depolarizing events that occur in lumbar motoneurons during REM periods of active sleep | Q48820984 | ||
Pharyngeal narrowing/occlusion during central sleep apnea | Q48821308 | ||
Respiratory and cardiovascular responses to increased and decreased carotid sinus pressure in sleeping dogs | Q48821325 | ||
Sleep apnoea and nocturnal angina. | Q48821990 | ||
Pulmonary hypertension in obstructive sleep apnoea | Q48822927 | ||
Platelet Function and Fibrinolytic Activity in Hypertensive and Normotensive Sleep Apnea Patients | Q48823182 | ||
Body fat distribution and sleep apnea severity in women | Q48824946 | ||
Family studies in patients with the sleep apnea-hypopnea syndrome | Q48825036 | ||
Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications | Q48825408 | ||
Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure | Q48827357 | ||
Sleep apnea in patients with hemispheric stroke | Q48827370 | ||
Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness | Q48829306 | ||
Impairment of cerebral perfusion during obstructive sleep apneas | Q48829441 | ||
Effects of REM sleep on the ventilatory response to airway occlusion in the dog. | Q48830297 | ||
Central respiratory activity in rapid eye movement sleep: augmenting and late inspiratory cells [corrected] | Q48830306 | ||
Respiratory muscle activity during sleep-induced periodic breathing in the elderly | Q48830987 | ||
Apnea after normocapnic mechanical ventilation during NREM sleep | Q48831015 | ||
Insulin levels, blood pressure and sleep apnea. | Q48832253 | ||
Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment | Q48833064 | ||
Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea | Q48835890 | ||
Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers | Q48835975 | ||
A volume-dependent apneic threshold during NREM sleep in the dog. | Q48843287 | ||
Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors | Q48846731 | ||
ST-segment depression during obstructive sleep apnea | Q48846744 | ||
Effect of chemoreceptor stimulation and inhibition on total pulmonary resistance in humans during NREM sleep | Q48847268 | ||
Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome | Q48851176 | ||
Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing | Q48859276 | ||
Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea | Q48862328 | ||
Effects of rapid-eye-movement sleep on the apneic threshold in dogs | Q48863592 | ||
Laryngeal response to passively induced hypocapnia during NREM sleep in normal adult humans | Q48863604 | ||
Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study | Q48864091 | ||
Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients | Q48865967 | ||
ST-segment depression during sleep in obstructive sleep apnea | Q48867762 | ||
Augmented resting sympathetic activity in awake patients with obstructive sleep apnea | Q48867897 | ||
Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea | Q48868124 | ||
Molecular and physiologic basis of obstructive sleep apnea | Q35151647 | ||
Hypertension and obstructive sleep apnea | Q35209080 | ||
Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging | Q35533055 | ||
Pulmonary arterial hypertension in patients with sleep apnoea syndrome | Q35533481 | ||
Association of serum leptin with hypoventilation in human obesity | Q35534789 | ||
Craniofacial profile in Asian and white subjects with obstructive sleep apnoea | Q35537704 | ||
Serotonin2 receptors in the nucleus tractus solitarius: characterization and role in the baroreceptor reflex arc | Q35545559 | ||
Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome | Q48710576 | ||
Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea | Q48711993 | ||
Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea | Q48712448 | ||
Neurocirculatory consequences of intermittent asphyxia in humans | Q48712967 | ||
Upper airway muscle responsiveness to rising PCO(2) during NREM sleep | Q48712976 | ||
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy | Q48713863 | ||
Endogenous excitatory drive to the respiratory system in rapid eye movement sleep in cats | Q48714864 | ||
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy | Q48716348 | ||
Association of hypertension and sleep-disordered breathing | Q48716637 | ||
Increased vasoconstrictor sensitivity in obstructive sleep apnea | Q48716681 | ||
Local mechanisms drive genioglossus activation in obstructive sleep apnea. | Q48722362 | ||
Ventilatory responses to specific CNS hypoxia in sleeping dogs | Q48722647 | ||
Predictors of improvements in daytime function outcomes with CPAP therapy | Q48728579 | ||
Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea | Q48728776 | ||
Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea | Q48729153 | ||
Sleep-disordered breathing among patients with first-ever stroke | Q48729312 | ||
Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack | Q48731769 | ||
Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. | Q48735827 | ||
Hypoglossal motoneurons are postsynaptically inhibited during carbachol-induced rapid eye movement sleep | Q48736196 | ||
Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. | Q48737296 | ||
Acute and chronic effects of airway obstruction on canine left ventricular performance | Q48737323 | ||
Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment | Q48737933 | ||
The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog | Q48739007 | ||
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure | Q48741847 | ||
Chronic intermittent hypoxia increases haematocrit and causes right ventricular hypertrophy in the rat. | Q48742479 | ||
An independent association between obstructive sleep apnoea and coronary artery disease | Q48744179 | ||
Patients with obstructive sleep apnea have an abnormal peripheral vascular response to hypoxia | Q48744641 | ||
Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy | Q48748953 | ||
Sleep apnea syndrome and cerebral hemodynamics | Q48752136 | ||
The effect of adenotonsillectomy on serum insulin-like growth factor-I and growth in children with obstructive sleep apnea syndrome | Q48755930 | ||
Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome | Q48762066 | ||
Acute and chronic blood pressure response to recurrent acoustic arousal in rats | Q48762593 | ||
Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems | Q48764895 | ||
Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease | Q48764914 | ||
Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure | Q48764933 | ||
Leptin prevents respiratory depression in obesity | Q48764953 | ||
Inhibition of inspiratory motor output by high-frequency low-pressure oscillations in the upper airway of sleeping dogs. | Q48765076 | ||
Sleep apnea in acute cerebrovascular diseases: final report on 128 patients | Q48766715 | ||
Baroreflex control of heart rate in a canine model of obstructive sleep apnea | Q48767973 | ||
Effects of obstructive sleep apnea on endothelin-1 and blood pressure. | Q48768740 | ||
Influence of pulmonary capillary wedge pressure on central apnea in heart failure | Q48768829 | ||
Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. | Q48770394 | ||
Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. | Q48771805 | ||
Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea | Q48772436 | ||
Polysomnography and maintenance of wakefulness test as predictors of CPAP effectiveness in obstructive sleep apnea | Q48773101 | ||
Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia | Q48774498 | ||
Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation. | Q48775593 | ||
Progressive retropalatal narrowing preceding obstructive apnea. | Q48779079 | ||
Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome. | Q48779531 | ||
Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects | Q48785494 | ||
Activity of serotonin-containing neurons in the nucleus raphe pallidus of freely moving cats | Q48872432 | ||
Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). | Q48873426 | ||
Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing | Q48874085 | ||
Determinants of poststimulus potentiation in humans during NREM sleep | Q48882115 | ||
Stroke volume and cardiac output decrease at termination of obstructive apneas | Q48882125 | ||
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats | Q48886060 | ||
Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea | Q48886308 | ||
Histopathologic changes in snoring and obstructive sleep apnea syndrome | Q48895331 | ||
Prevention of airway obstructions during sleep in infants with breath-holding spells by means of oral belladonna: a prospective double-blind crossover evaluation | Q48898591 | ||
Response of Obstructive Sleep Apnea to Fluoxetine and Protriptyline | Q48902274 | ||
Effect of Hypercapnia on Total Pulmonary Resistance during Wakefulness and during NREM Sleep | Q48902370 | ||
Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. | Q48919880 | ||
Effects of sleep-induced increases in upper airway resistance on ventilation | Q48922295 | ||
Waking and genioglossus muscle responses to upper airway pressure oscillation in sleeping dogs | Q48923432 | ||
Effect of lung inflation on pulmonary resistance during NREM sleep | Q48925606 | ||
Cephalometric evaluation of pharyngeal obstructive factors in patients with sleep apneas syndrome | Q48930190 | ||
Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients | Q48937004 | ||
Morphology of the uvula in obstructive sleep apnea | Q48938620 | ||
Respiration and abnormal sleep in patients with congestive heart failure | Q48938749 | ||
Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy | Q48946653 | ||
Presynaptic inhibition of glutamatergic synaptic transmission to rat motoneurons by serotonin | Q48949615 | ||
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? | Q48950794 | ||
Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome | Q48955167 | ||
Inhibition of inspiratory muscle activity during sleep. Chemical and nonchemical influences | Q48956427 | ||
Obstructive sleep apnea and cephalometric roentgenograms. The role of anatomic upper airway abnormalities in the definition of abnormal breathing during sleep | Q48957305 | ||
Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone | Q48959349 | ||
Upper airway pressure-flow relationships in obstructive sleep apnea | Q48960423 | ||
Serotonergic effects on hypoglossal neural activity and reflex responses | Q48965282 | ||
Comparison of the response of diaphragm and upper airway dilating muscle activity in sleeping cats | Q48969055 | ||
Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep | Q48983400 | ||
Effect of hypoxia-induced periodic breathing on upper airway obstruction during sleep | Q48985430 | ||
A sleep-induced apneic threshold and its consequences | Q49011346 | ||
A possible mechanism for mixed apnea in obstructive sleep apnea | Q49012144 | ||
Serotonergic and noradrenergic effects on respiratory neural discharge in the medullary slice preparation of neonatal rats | Q49017292 | ||
Sleep apnea and pulmonary hypertension | Q49018369 | ||
Undiagnosed sleep apnea in patients with essential hypertension | Q49038713 | ||
Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome | Q49041960 | ||
Sleep apnea syndrome and essential hypertension | Q49045570 | ||
Nicotine: a different approach to treatment of obstructive sleep apnea | Q49054158 | ||
Induction of airway collapse with subatmospheric pressure in awake patients with sleep apnea | Q49073309 | ||
Upper airway morphology in patients with idiopathic obstructive sleep apnea | Q49083087 | ||
Effects of slow wave sleep on ventilatory compensation to inspiratory elastic loading | Q49087961 | ||
Reduced stroke volume related to pleural pressure in obstructive sleep apnea | Q49098116 | ||
Mechanisms of hypoxia-induced periodic breathing during sleep in humans | Q49104073 | ||
Investigating the relationship between stroke and obstructive sleep apnea. | Q49105399 | ||
Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation | Q49105780 | ||
Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome | Q49105960 | ||
Inspiratory and expiratory partitioning of airway resistance during sleep in patients with sleep apnea | Q49112575 | ||
Cephalometric analyses and flow-volume loops in obstructive sleep apnea patients | Q49122316 | ||
Factors inducing periodic breathing in humans: a general model | Q49134449 | ||
Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment | Q70216514 | ||
Influence of upper airway pressure changes on genioglossus muscle respiratory activity | Q70219449 | ||
Oropharyngeal muscle tone in obstructive sleep apnea before and after strychnine | Q70742224 | ||
5-HT2 receptor-controlled modulation of medullary respiratory neurones in the cat | Q70845792 | ||
The effects of serotonin antagonists in an animal model of sleep-disordered breathing | Q70906266 | ||
Influence of treatment on muscle sympathetic nerve activity in sleep apnea | Q71046220 | ||
Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines | Q71078731 | ||
Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome | Q71147324 | ||
Hypoxemia during apnea in normal subjects: mechanisms and impact of lung volume | Q71168888 | ||
Laryngeal receptors responding to transmural pressure, airflow and local muscle activity | Q71202053 | ||
Pharmacological characterization of serotonin receptors in the facial motor nucleus: a microiontophoretic study | Q71265425 | ||
Phasic volume-related feedback on upper airway muscle activity | Q71300070 | ||
Negative pressure-induced deformation of the upper airway causes central apnea in awake and sleeping dogs | Q71314467 | ||
Neurocirculatory consequences of abrupt change in sleep state in humans | Q71314529 | ||
Diaphragmatic and genioglossal electromyogram responses to isocapnic hypoxia in humans | Q71569447 | ||
Effects of vasodilators on hypoxic pulmonary vasoconstriction in normal man | Q71618840 | ||
Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls | Q71796369 | ||
Airway obstruction during sleep increases blood pressure without arousal | Q71886003 | ||
Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure | Q71891689 | ||
Modification of mastication and respiration during swallowing in the adult human | Q71958971 | ||
ATP modulation of synaptic transmission in the spinal substantia gelatinosa | Q72240775 | ||
Determinants of maximal expiratory flow from the lungs | Q72317246 | ||
Ventilatory afterdischarge and central respiratory drive interactions in the awake goat | Q72403158 | ||
Development of thyrotropin-releasing hormone and norepinephrine potentiation of inspiratory-related hypoglossal motoneuron discharge in neonatal and juvenile mice in vitro | Q72616516 | ||
Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure | Q72860707 | ||
Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease | Q73092761 | ||
Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects | Q73092998 | ||
Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea | Q73165458 | ||
Role of 5HT1 receptors in the control of hypoglossal motoneurons in vivo | Q73187641 | ||
Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging | Q73251630 | ||
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity | Q73320092 | ||
Circulating endothelin-1 in obstructive sleep apnea | Q73544211 | ||
Cerebrovascular reactivity and subcortical infarctions | Q73735298 | ||
Hemodynamics, cerebral circulation, and oxygen saturation in Cheyne-Stokes respiration | Q73807063 | ||
The effect of altitude hypoxia on glucose homeostasis in men | Q73831550 | ||
Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep | Q73885902 | ||
Pulmonary hypertension in patients with obstructive sleep apnea syndrome | Q73912549 | ||
An induced blood pressure rise does not alter upper airway resistance in sleeping humans | Q74126007 | ||
Sleep-disordered breathing in children | Q74129549 | ||
Association of low PaCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure | Q74137585 | ||
Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system | Q74261920 | ||
Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits | Q74324545 | ||
Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea | Q74405737 | ||
Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment | Q74463133 | ||
Exposure to hypoxia produces long-lasting sympathetic activation in humans | Q74542436 | ||
Respiration and wakefulness in man | Q76458458 | ||
Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide | Q77293229 | ||
Quantitation of chemoreceptor activity: interrelation of hypoxia and hypercapnia | Q78929106 | ||
5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors | Q79213470 | ||
Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia | Q79511818 | ||
Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease | Q79597968 | ||
Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress | Q79733817 | ||
5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase | Q80057764 | ||
Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits | Q83227640 | ||
Ventilatory adaptations to resistive loading during wakefulness and non-REM sleep | Q49146036 | ||
Pathogenesis of apneas in hypersomnia-sleep apnea syndrome | Q49148060 | ||
Sleep-disordered breathing and poor functional outcome after stroke | Q49157537 | ||
Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle | Q49162619 | ||
Depressed baroreflex sensitivity in patients with obstructive sleep apnea. | Q50993314 | ||
Sleep-disordered breathing in women: occurrence and association with coronary artery disease. | Q50999358 | ||
Studies on the respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid | Q51238223 | ||
Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the pickwick syndrome | Q51239571 | ||
The reticular activating system and respiratory regulation in the cat. | Q51285533 | ||
Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. | Q51572827 | ||
Serotonin 1A-receptor activation suppresses respiratory apneusis in the cat. | Q51633937 | ||
Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. | Q51690158 | ||
Upper airway negative-pressure effects on respiratory activity of upper airway muscles. | Q51848221 | ||
Respiratory-related hypoglossal nerve activity: influence of anesthetics. | Q51851882 | ||
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. | Q52026600 | ||
Interaction of cross-sectional area, driving pressure, and airflow of passive velopharynx. | Q52256635 | ||
Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. | Q52312223 | ||
Dynamic imaging of the upper airway during respiration in normal subjects. | Q52397685 | ||
Influence of passive changes of lung volume on upper airways. | Q52866740 | ||
Maximum Nasal Inspiratory Flow and Nasal Resistance | Q53008986 | ||
Apparent CBF decrease with normal aging due to partial volume effects: MR-based partial volume correction on CBF SPECT. | Q53574032 | ||
Pharmacological studies of facial motoneurones in the rat. | Q53701417 | ||
Neural mechanism of the pressor response to obstructive and nonobstructive apnea. | Q53794129 | ||
Central neural respiratory stimulatory effect of active respiration. | Q54122856 | ||
Actions of norepinephrine on rat hypoglossal motoneurons. | Q54158533 | ||
Adenosine suppresses excitatory glutamatergic inputs to rat hypoglossal motoneurons in vitro. | Q54197519 | ||
Influence of lung volume dependence of upper airway resistance during continuous negative airway pressure. | Q54198339 | ||
Effect of tracheotomy in hypersomnia with periodic respiration. | Q54253301 | ||
Nasal and pharyngeal resistance after topical mucosal vasoconstriction in normal humans. | Q54284802 | ||
Thoracic influence on upper airway patency. | Q54373761 | ||
Hemodynamics of the Mueller maneuver in man: right and left heart micromanometry and Doppler echocardiography. | Q54397477 | ||
Effect of beta-adrenergic agonists on apnea reflexes in newborn lambs. | Q54500793 | ||
Effect of chemical stimuli on nerves supplying upper airway muscles. | Q54520337 | ||
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. | Q54709411 | ||
Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. | Q55037941 | ||
Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality | Q57085545 | ||
The Partial 5-Hydroxytryptamine1A Receptor Agonist Buspirone does not Antagonize Morphine-induced Respiratory Depression in Humans | Q60678545 | ||
Sleep-Disordered Breathing in Men With Coronary Artery Disease | Q60687134 | ||
Effects of graded reduction of brain blood flow on chemical control of breathing | Q66993783 | ||
Pathogenesis of upper airway occlusion during sleep | Q67355497 | ||
Regulation of respiration in sleeping dogs | Q67738701 | ||
Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep | Q67876016 | ||
Ventricular Function in Snorers and Patients with Obstructive Sleep Apnea | Q68194031 | ||
Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema | Q68543610 | ||
Insomnia with sleep apnea: a new syndrome | Q68665477 | ||
Noradrenergic modulation of the masseteric reflex in behaving cats. I. Pharmacological studies | Q68700993 | ||
Serotonin and co-localized peptides: effects on spinal motoneuron excitability | Q68951049 | ||
Variable site of airway narrowing among obstructive sleep apnea patients | Q69663735 | ||
P433 | issue | 1 | |
P921 | main subject | sleep apnea | Q213600 |
pathophysiology | Q1135939 | ||
sleep | Q35831 | ||
P304 | page(s) | 47-112 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Physiological Reviews | Q1091827 |
P1476 | title | Pathophysiology of sleep apnea | |
P478 | volume | 90 |
Q47943414 | 14th Annual Meeting of the Safety Pharmacology Society: Threading through peripheral and central nervous system presentations |
Q40604494 | A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial |
Q36323277 | A Comparative Analysis of Sleep Disordered Breathing in Active Duty Service Members with and without Combat-Related Posttraumatic Stress Disorder |
Q90814533 | A Comparative Study of ECG-derived Respiration in Ambulatory Monitoring using the Single-lead ECG |
Q27316294 | A Subject-Specific Acoustic Model of the Upper Airway for Snoring Sounds Generation |
Q33945216 | A critical assessment of monitoring practices, patient deterioration, and alarm fatigue on inpatient wards: a review. |
Q46421055 | A microfluidic system for studying the behavior of zebrafish larvae under acute hypoxia |
Q38935393 | A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients |
Q30557443 | A new rodent model for obstructive sleep apnea: effects on ATP-mediated dilations in cerebral arteries |
Q90628350 | A reminder that experimentally induced intermittent hypoxia is an incomplete model of obstructive sleep apnea and its outcome measures |
Q38679035 | A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy |
Q45327012 | Aberrant cortical neuroplasticity in the OSA patient (Commentary on Opie et al.). |
Q48256199 | Abnormal mitochondria organization and oxidative activity in the palate muscles of long-term snorers with obstructive sleep apnea |
Q53426240 | Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) Core Measures: Behavioral Domain. |
Q55340704 | Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea. |
Q48089091 | Acoustic estimation of neck fluid volume |
Q93382506 | Acoustic respiration rate and pulse oximetry-derived respiration rate: a clinical comparison study |
Q37578261 | Activation of upper airway muscles during breathing and swallowing |
Q34333944 | Acute exacerbation of sleep apnea by hyperoxia impairs cognitive flexibility in Brown-Norway rats |
Q84450412 | Acute intermittent hypoxia in rat in vivo elicits a robust increase in tonic sympathetic nerve activity that is independent of respiratory drive |
Q48207635 | Acute upper airway muscle and inspiratory flow responses to transcranial magnetic stimulation during sleep in apnoeic patients |
Q36956274 | Adaptive responses using obstructive sleep apnea as the paradigm |
Q37540226 | Adult obstructive sleep apnoea. |
Q52574725 | Afferent Neural Feedback Overrides the Modulating Effects of Arousal, Hypercapnia and Hypoxemia on Neonatal Cardio-respiratory Control. |
Q46612444 | Age protects from harmful effects produced by chronic intermittent hypoxia |
Q64276876 | Airflow limitation in a collapsible model of the human pharynx: physical mechanisms studied with fluid-structure interaction simulations and experiments |
Q47638488 | Airway obstruction produces widespread sympathoexcitation: role of hypoxia, carotid chemoreceptors, and NTS neurotransmission |
Q42361196 | Alteration of Inflammatory Mediators in the Upper and Lower Airways under Chronic Intermittent Hypoxia: Preliminary Animal Study. |
Q35059201 | Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA |
Q35884314 | Among Metabolic Factors, Significance of Fasting and Postprandial Increases in Acyl and Desacyl Ghrelin and the Acyl/Desacyl Ratio in Obstructive Sleep Apnea before and after Treatment |
Q36152606 | An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia |
Q47404562 | Analyses of aerodynamic characteristics of the oropharynx applying CBCT: obstructive sleep apnea patients versus control subjects |
Q44017897 | Analysis of anatomical and functional determinants of obstructive sleep apnea |
Q64859151 | Androgens modulate chronic intermittent hypoxia effects on brain and behavior |
Q35138604 | Angiotensin II type 1a receptors in subfornical organ contribute towards chronic intermittent hypoxia-associated sustained increase in mean arterial pressure |
Q33740901 | Angiotensin converting enzyme 1 in the median preoptic nucleus contributes to chronic intermittent hypoxia hypertension |
Q92502115 | Angiotensin type 1a receptors in the median preoptic nucleus support intermittent hypoxia-induced hypertension |
Q36761993 | Animal models of sleep disorders |
Q92191128 | Ankylosing Spondylitis Is Associated With Risk of New-Onset Obstructive Sleep Apnea: A Nationwide Population-Based Cohort Study |
Q37941172 | Annual review of selected scientific literature: report of the committee on scientific investigation of the American Academy of Restorative Dentistry |
Q36531042 | Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus |
Q30460832 | Antimony and sleep-related disorders: NHANES 2005-2008. |
Q45999442 | Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea. |
Q64069099 | Apnea causes microvascular perfusion maldistribution in isolated rat lungs |
Q47800649 | Apneic events - A proposed new target for respiratory safety pharmacology |
Q47789087 | Applicability of predictive equations for resting energy expenditure in obese patients with obstructive sleep apnea |
Q48367687 | Are home ventilators able to guarantee a minimal tidal volume? |
Q37301951 | Are nocturnal breathing, sleep, and cognitive performance impaired at moderate altitude (1,630-2,590 m)? |
Q44601208 | Arousals are frequent and associated with exacerbated blood pressure response in patients with primary hypertension |
Q47742096 | Assessment of tongue mechanical properties using different contraction tasks |
Q39123858 | Association Between Sleep-Disordered Breathing and Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus |
Q47739016 | Association between Sleep Disordered Breathing and Nighttime Driving Performance in Mild Cognitive Impairment |
Q35100289 | Association between asthma and risk of developing obstructive sleep apnea |
Q92000972 | Association of Adipocytokines With Carotid Intima Media Thickness and Arterial Stiffness in Obstructive Sleep Apnea Patients |
Q50355655 | Association of obstructive sleep apnea with hypertension: A systematic review and meta-analysis |
Q47947249 | Augmented cardiovascular responses to episodes of repetitive compared with isolated respiratory events in preschool children with sleep-disordered breathing. |
Q58484011 | Baroreflex control of muscle sympathetic nerve activity as a mechanism for persistent sympathoexcitation following acute hypoxia in humans |
Q42128532 | Bench test evaluation of adaptive servoventilation devices for sleep apnea treatment |
Q60919539 | Benzodiazepines Associated With Acute Respiratory Failure in Patients With Obstructive Sleep Apnea |
Q41457855 | Blockade of Na+/H+ exchanger type 3 causes intracellular acidification and hyperexcitability via inhibition of pH-sensitive K+ channels in chemosensitive respiratory neurons of the dorsal vagal nucleus in rats |
Q37628119 | Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk |
Q30411461 | C1 neurons: the body's EMTs |
Q38076337 | CBCT assessment of upper airway changes and treatment outcomes of obstructive sleep apnoea: a systematic review |
Q37364077 | Cardiac autonomic control in Brugada syndrome patients during sleep: the effects of sleep disordered breathing |
Q35366061 | Cardiac autonomic control in the obstructive sleep apnea |
Q61454624 | Cardiac rhythm disorders in obstructive sleep apnea |
Q35144144 | Cardio-respiratory coordination increases during sleep apnea. |
Q55241616 | Cardiovascular Disease Risk in Obstructive Sleep apnea: An Update. |
Q47731161 | Cardiovascular Effects of Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Meta-Analysis. |
Q48275734 | Cardiovascular consequences of sleep apnea |
Q92090998 | Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles |
Q41870453 | Cardiovascular responses induced by obstructive apnea are enhanced in hypertensive rats due to enhanced chemoreceptor responsivity |
Q42722134 | Career perspective: Jerome A. Dempsey |
Q88779835 | Carotid Body Ablation: a New Target to Address Central Autonomic Dysfunction |
Q28076487 | Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease |
Q38913121 | Carotid body chemoreflex: a driver of autonomic abnormalities in sleep apnoea |
Q34495929 | Carotid body potentiation during chronic intermittent hypoxia: implication for hypertension |
Q34419319 | Carotid body, insulin, and metabolic diseases: unraveling the links |
Q40121464 | Catecholaminergic A1/C1 neurons contribute to the maintenance of upper airway muscle tone but may not participate in NREM sleep-related depression of these muscles |
Q37513401 | Central and peripheral factors contributing to obstructive sleep apneas |
Q39999646 | Central respiratory chemosensitivity and cerebrovascular CO2 reactivity: a rebreathing demonstration illustrating integrative human physiology |
Q91812122 | Central sleep apnea: misunderstood and mistreated! |
Q36366284 | Cerebrovascular consequences of obstructive sleep apnea |
Q34887628 | Cerebrovascular reactivity in young subjects with sleep apnea. |
Q38716737 | Change in End-Expiratory Lung Volume During Sleep in Patients at Risk for Obstructive Sleep Apnea |
Q34553063 | Chemogenetic stimulation of the hypoglossal neurons improves upper airway patency |
Q26825346 | Chemoreception and asphyxia-induced arousal |
Q34598170 | Chemoreflexes, sleep apnea, and sympathetic dysregulation |
Q40471661 | Chronic Influences of Obstructive Sleep Apnea on Cerebral Venous Flow. |
Q36541176 | Chronic Intermittent Hypoxia Alters Local Respiratory Circuit Function at the Level of the preBötzinger Complex. |
Q41705938 | Chronic Intermittent Hypoxia Differentially Impacts Different States of Inspiratory Activity at the Level of the preBötzinger Complex |
Q26783756 | Chronic hypoventilation syndromes and sleep-related hypoventilation |
Q38593059 | Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review |
Q35086929 | Chronic intermittent hypoxia increases blood pressure and expression of FosB/DeltaFosB in central autonomic regions |
Q51764236 | Chronic intermittent hypoxia induces hormonal and male sexual behavioral changes: Hypoxia as an advancer of aging. |
Q33679761 | Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration |
Q60301442 | Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease |
Q38101728 | Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease |
Q39413926 | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity |
Q30389382 | Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite |
Q36791654 | Cognition and biomarkers of oxidative stress in obstructive sleep apnea |
Q33806219 | Combination of erythropoietin and sildenafil can effectively attenuate hypoxia-induced pulmonary hypertension in mice |
Q48278669 | Combined effect of obstructive sleep apnea and age on daytime blood pressure |
Q38111142 | Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders |
Q36808834 | Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study |
Q36603628 | Comparative evaluation of craniofacial anthropometric measurements in Indian adult patients with and without obstructive sleep apnea: A pilot study |
Q89866358 | Comparison between blood pressure during obstructive respiratory events in REM and NREM sleep using pulse transit time |
Q37095489 | Comparison of Sleep Disorders between Real and Simulated 3,450-m Altitude |
Q92795879 | Comparison of upper airway measurement by lateral cephalogram in upright position and CBCT in supine position |
Q48148793 | Complex sleep apnea |
Q37964622 | Computational models for the study of heart-lung interactions in mammals |
Q43457674 | Consecutive transcranial magnetic stimulation twitches reduce flow limitation during sleep in apnoeic patients |
Q47364059 | Consequences of maternal omega-3 polyunsaturated fatty acid supplementation on respiratory function in rat pups. |
Q58710225 | Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial |
Q90533496 | Contribution of Oxidative Stress and Inflammation to the Neurogenic Hypertension Induced by Intermittent Hypoxia |
Q24634619 | Control of sleep and wakefulness |
Q44747950 | Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in Obstructive Sleep Apnea. |
Q53681657 | Correlation between metabolic syndrome and sleep apnea. |
Q42723886 | Correlation of obstructive sleep apnea hypopnea syndrome with metabolic syndrome in snorers |
Q42217838 | Critical Role of Endoplasmic Reticulum Stress in Chronic Intermittent Hypoxia-Induced Deficits in Synaptic Plasticity and Long-Term Memory |
Q48093832 | CrossTalk opposing view: Loop gain is not a consequence of obstructive sleep apnoea |
Q48173273 | CrossTalk proposal: the human upper airway does behave like a Starling resistor during sleep |
Q35682939 | Crossed motor innervation of the base of human tongue |
Q47943982 | Crucial Role of the Carotid Body Chemoreceptors on the Development of High Arterial Blood Pressure During Chronic Intermittent Hypoxia |
Q58700894 | Culturally tailored, peer-based sleep health education and social support to increase obstructive sleep apnea assessment and treatment adherence among a community sample of blacks: study protocol for a randomized controlled trial |
Q46259726 | DNA methylation in the central and efferent limbs of the chemo reflex requires carotid body neural activity |
Q38080761 | Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome |
Q35478501 | Decreased Regional Cerebral Perfusion in Moderate-Severe Obstructive Sleep Apnoea during Wakefulness. |
Q64245857 | Desmin and dystrophin abnormalities in upper airway muscles of snorers and patients with sleep apnea |
Q42363825 | Development of a Clinical Pathway and Technical Aspects of Upper Airway Stimulation Therapy for Obstructive Sleep Apnea |
Q37060214 | Development of autonomic dysfunction with intermittent hypoxia in a lean murine model |
Q37227528 | Developmental changes in the morphology of mouse hypoglossal motor neurons |
Q28067077 | Diagnosis of Obstructive Sleep Apnea Syndrome in Adults: A Brief Review of Existing Data for Practice in Iran |
Q47562447 | Diagnostic accuracy of level IV portable sleep monitors versus polysomnography for obstructive sleep apnea: a systematic review and meta-analysis. |
Q47682789 | Diagnostic performance of cheeks appearance in sleep apnea |
Q36999754 | Diaphragm muscle remodeling in a rat model of chronic intermittent hypoxia |
Q35142653 | Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury |
Q39403276 | Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk |
Q37094674 | Different Craniofacial Characteristics Predict Upper Airway Collapsibility in Japanese-Brazilian and White Men. |
Q90601927 | Differential expression of immune markers in the patients with obstructive sleep apnea/hypopnea syndrome |
Q47905401 | Does experimental paradoxical sleep deprivation (EPSD) is an appropriate model for evaluation of cardiovascular complications of obstructive sleep apnea? |
Q34235233 | Does race-ethnicity moderate the relationship between CPAP adherence and functional outcomes of sleep in US veterans with obstructive sleep apnea syndrome? |
Q40157811 | Downregulation of uncoupling protein-1 mRNA expression and hypoadiponectinemia in a mouse model of sleep apnea. |
Q40021922 | Drug trials for obstructive sleep apnea. |
Q38602645 | Drug-induced sedation endoscopy versus clinical exploration for the diagnosis of severe upper airway obstruction in OSAHS patients |
Q59340090 | ENT and mucopolysaccharidoses |
Q47935780 | Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea |
Q55256781 | Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance. |
Q55516492 | Effect of Gender on Chronic Intermittent Hypoxic Fosb Expression in Cardiorespiratory-Related Brain Structures in Mice. |
Q53408826 | Effect of Rapid Eye Movement Sleep Behavior Disorder on Obstructive Sleep Apnea Severity and Cognition of Parkinson's Disease Patients. |
Q38886533 | Effect of Sleeping Position on Upper Airway Patency in Obstructive Sleep Apnea Is Determined by the Pharyngeal Structure Causing Collapse |
Q35951157 | Effect of chronic intermittent hypoxia on noradrenergic activation of hypoglossal motoneurons |
Q35544844 | Effect of diuretics and sodium-restricted diet on sleep apnea severity: study protocol for a randomized controlled trial |
Q47728243 | Effect of modern surgical treatment on the inflammatory/anti-inflammatory balance in patients with obstructive sleep apnoea |
Q38260517 | Effect of sedative-hypnotics, anesthetics and analgesics on sleep architecture in obstructive sleep apnea |
Q42206349 | Effect of sleep on breathing - Why recurrent apneas are only seen during sleep |
Q41623574 | Effect of transoral endoscopic adenoidectomy on peripheral blood T-lymphocyte subsets in children with obstructive sleep apnea-hypopnea syndrome and its treatment strategy |
Q51730788 | Effects of Bedroom Environmental Conditions on the Severity of Obstructive Sleep Apnea. |
Q47682676 | Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats |
Q57819508 | Effects of Increased Pharyngeal Tissue Mass Due to Fluid Accumulation in the Neck on the Acoustic Features of Snoring Sounds in Men |
Q30368951 | Effects of Obstructive Sleep Apnea and Obesity on Cardiac Remodeling: The Wisconsin Sleep Cohort Study. |
Q64109656 | Effects of an Adenotonsillectomy on the Cognitive and Behavioural Function of Children Who Snore: A naturalistic observational study |
Q37518432 | Effects of chronic sleep fragmentation on wake-active neurons and the hypercapnic arousal response |
Q48021825 | Effects of dorsomedial medullary 5-HT2 receptor antagonism on initial ventilatory airway responses to hypercapnic hypoxia in mice |
Q38110759 | Effects of gas exchange on acid-base balance. |
Q37505948 | Effects of inhaled fluticasone on upper airway during sleep and wakefulness in asthma: a pilot study |
Q35222160 | Effects of orexin 2 receptor activation on apnea in the C57BL/6J mouse |
Q47811378 | Effects of repetitive transcranial magnetic stimulation of upper airway muscles during sleep in obstructive sleep apnea patients |
Q37054675 | Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea |
Q90177552 | Efficacy and adherence of auto-CPAP therapy in patients with obstructive sleep apnea: a prospective study |
Q38668431 | Electrical stimulation for the treatment of obstructive sleep apnoea: a review of the evidence |
Q52728801 | Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA). |
Q34300711 | Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia |
Q34608364 | Enhanced carotid body chemosensory activity and the cardiovascular alterations induced by intermittent hypoxia |
Q30366078 | Enhanced non-eupneic breathing following hypoxic, hypercapnic or hypoxic-hypercapnic gas challenges in conscious mice. |
Q40177344 | Environmental Enrichment Prevent the Juvenile Hypoxia-Induced Developmental Loss of Parvalbumin-Immunoreactive Cells in the Prefrontal Cortex and Neurobehavioral Alterations Through Inhibition of NADPH Oxidase-2-Derived Oxidative Stress |
Q47929499 | Enzalutamide and sleep apnea: an emerging central nervous system side-effect? |
Q35832711 | Epigenomic profiling in visceral white adipose tissue of offspring of mice exposed to late gestational sleep fragmentation. |
Q48049049 | Erythropoietin does not have effects on the ventilatory and pulmonary vascular response to acute hypoxia in men and women |
Q30419870 | Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders |
Q98465633 | Evaluation of Serum and Plasma Interleukin-6 Levels in Obstructive Sleep Apnea Syndrome: A Meta-Analysis and Meta-Regression |
Q51730785 | Evaluation of a Trial Period With a Sleep Position Trainer in Patients With Positional Sleep Apnea. |
Q41090861 | Evaluation of the predictive value of red blood cell distribution width for onset of cerebral infarction in the patients with obstructive sleep apnea hypopnea syndrome |
Q39173365 | Evening and morning peroxiredoxin-2 redox/oligomeric state changes in obstructive sleep apnea red blood cells: Correlation with polysomnographic and metabolic parameters |
Q35677223 | Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats |
Q34575701 | Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea |
Q34663312 | Experimental protocols and preparations to study respiratory long term facilitation |
Q34062951 | Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxide |
Q45132502 | Factors influencing the response of psychological symptoms to continuous positive airway pressure therapy |
Q54116553 | Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway. |
Q48243276 | Filling in the pieces of the sleep apnea-hypertension puzzle |
Q42604098 | Fingerprinting-based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: a pilot study. |
Q35023591 | Frequent periodic leg movement during sleep is an unrecognized risk factor for progression of atrial fibrillation |
Q47942661 | Functional outcome of tongue motions with selective hypoglossal nerve stimulation in patients with obstructive sleep apnea |
Q26827948 | Future of Sleep-Disordered Breathing Therapy Using a Mechanistic Approach |
Q37364745 | Growth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse |
Q55380515 | Guinea Pig as a Model to Study the Carotid Body Mediated Chronic Intermittent Hypoxia Effects. |
Q46487608 | Hepatic Cyp1a2 Expression Reduction during Inflammation Elicited in a Rat Model of Intermittent Hypoxia |
Q35130266 | Hepatic oxidative stress in an animal model of sleep apnoea: effects of different duration of exposure |
Q36234613 | Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease |
Q37678352 | High intensity aerobic exercise training improves chronic intermittent hypoxia-induced insulin resistance without basal autophagy modulation |
Q46476087 | High risk for sleep apnea in the Berlin questionnaire and coronary artery disease |
Q36115297 | Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia |
Q35817898 | Humans In Hypoxia: A Conspiracy Of Maladaptation?! |
Q33714452 | Hypercapnia is a key correlate of EEG activation and daytime sleepiness in hypercapnic sleep disordered breathing patients |
Q47888286 | Hypercapnia is more important than hypoxia in the neuro-outcomes of sleep-disordered breathing |
Q50148800 | Hypoglossal Nerve Stimulation in a Pre-Clinical Anesthetized Rabbit Model Relevant to OSA. |
Q47799588 | Hypoxia-induced microRNA-26b inhibition contributes to hypoxic pulmonary hypertension via CTGF. |
Q30415118 | Hypoxia-induced ventilatory responses in conscious mice: gender differences in ventilatory roll-off and facilitation |
Q26768865 | Hypoxia: The Force that Drives Chronic Kidney Disease |
Q57099542 | Hypoxic pulmonary vasoconstriction |
Q41892767 | Identification of a pharmacological target for genioglossus reactivation throughout sleep |
Q33705228 | Impact of Compression Stockings vs. Continuous Positive Airway Pressure on Overnight Fluid Shift and Obstructive Sleep Apnea among Patients on Hemodialysis |
Q38009039 | Impact of breath holding on cardiovascular respiratory and cerebrovascular health |
Q38821538 | Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation. |
Q48009102 | Impact of rapid ascent to high altitude on sleep |
Q35787447 | Impact of repeated daily exposure to intermittent hypoxia and mild sustained hypercapnia on apnea severity |
Q36850754 | Inactivity-induced phrenic and hypoglossal motor facilitation are differentially expressed following intermittent vs. sustained neural apnea |
Q92341358 | Increase in the frequency of obstructive sleep apnea in elderly people |
Q36369678 | Increased Muscle Sympathetic Nerve Activity and Impaired Executive Performance Capacity in Obstructive Sleep Apnea. |
Q33723873 | Increased arterial stiffness in obstructive sleep apnea: a systematic review. |
Q34615048 | Increased cardio-respiratory coupling evoked by slow deep breathing can persist in normal humans |
Q35143486 | Increased cerebrovascular sensitivity to endothelin-1 in a rat model of obstructive sleep apnea: a role for endothelin receptor B |
Q36828589 | Increased sympathetic and decreased parasympathetic cardiac tone in patients with sleep related alveolar hypoventilation |
Q41007166 | Independent associations between arterial bicarbonate, apnea severity and hypertension in obstructive sleep apnea |
Q48349535 | Indomethacin-induced impairment of regional cerebrovascular reactivity: implications for respiratory control |
Q38293699 | Inflammation and oxidative stress during intermittent hypoxia: the impact on chemoreception. |
Q35137720 | Inflammation in sleep apnea: an update. |
Q47689143 | Inflammatory and oxidative stress‑associated factors in chronic intermittent hypoxia in Chinese patients, rats, lymphocytes and endotheliocytes |
Q45766091 | Influence of sleep apnea severity on blood pressure variability of patients with hypertension |
Q37736610 | Innate immunity modulation in the duodenal mucosa induced by REM sleep deprivation during infection with Trichinella spirallis |
Q47649290 | Insulin sensitivity, leptin, adiponectin, resistin, and testosterone in adult male and female rats after maternal-neonatal separation and environmental stress |
Q35976931 | Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation |
Q89673421 | Intermittent Hypoxia Augments Pulmonary Vasoconstrictor Reactivity through PKCβ/Mitochondrial Oxidant Signaling |
Q64251883 | Intermittent Hypoxia Up-Regulates Gene Expressions of in Enteroendocrine Cells |
Q36424244 | Intermittent Hypoxia-Induced Carotid Body Chemosensory Potentiation and Hypertension Are Critically Dependent on Peroxynitrite Formation |
Q34840423 | Intermittent hypoxemia and OSA: implications for comorbidities |
Q44011217 | Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure. |
Q47638275 | Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea |
Q37092265 | Intermittent hypoxia from obstructive sleep apnea may cause neuronal impairment and dysfunction in central nervous system: the potential roles played by microglia |
Q34197603 | Intermittent hypoxia mobilizes bone marrow-derived very small embryonic-like stem cells and activates developmental transcriptional programs in mice |
Q94671516 | Intermittent hypoxia modulates redox homeostasis, lipid metabolism associated inflammatory processes and redox post-translational modifications: Benefits at high altitude |
Q47767706 | Intermittent hypoxia revisited: a promising non-pharmaceutical strategy to reduce cardio-metabolic risk factors? |
Q35055945 | Intermittent hypoxia-induced sensitization of central chemoreceptors contributes to sympathetic nerve activity during late expiration in rats |
Q26824915 | Intermittent hypoxia: a low-risk research tool with therapeutic value in humans |
Q42328188 | Interventional Drug-Induced Sleep Endoscopy: A Novel Technique to Guide Surgical Planning for Obstructive Sleep Apnea |
Q38832964 | Intracranial mechanisms for preserving brain blood flow in health and disease |
Q36770920 | Intradialytic Hypoxemia and Clinical Outcomes in Patients on Hemodialysis. |
Q33672788 | Is C-reactive protein a marker of obstructive sleep apnea?: A meta-analysis |
Q35624212 | Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. |
Q36095782 | It takes a mouth to eat and a nose to breathe: abnormal oral respiration affects neonates' oral competence and systemic adaptation |
Q47774432 | Late gestational intermittent hypoxia induces metabolic and epigenetic changes in male adult offspring mice |
Q47685523 | Left ventricular strain rate is reduced during voluntary apnea in healthy humans. |
Q43746033 | Leptin signaling in the nucleus of the solitary tract alters the cardiovascular responses to activation of the chemoreceptor reflex |
Q35212608 | Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis |
Q33563733 | Lingual muscle activity across sleep-wake States in rats with surgically altered upper airway |
Q36203008 | Lower hypoxic ventilatory response in smokers compared to non-smokers during abstinence from cigarettes |
Q48034119 | MEMBRANE PROGESTERONE RECEPTOR β, BUT NOT α, IN DORSAL BRAINSTEM ESTABLISHES SEX-SPECIFIC CHEMOREFLEX RESPONSES AND REDUCES APNEA FREQUENCY IN ADULT MICE. |
Q92081261 | Magnitude and Determinants of Patients at Risk of Developing Obstructive Sleep Apnea in a Non-Communicable Disease Clinic |
Q36490066 | Making sense of oxidative stress in obstructive sleep apnea: mediator or distracter? |
Q99617415 | Managements for Obstructive Sleep Apnea in Adults: Review |
Q43944859 | Measurement of dyspnea in patients with obstructive sleep apnea |
Q47994056 | Mechanical effects of repetitive transcranial magnetic stimulation of upper airway muscles in awake obstructive sleep apnoea subjects |
Q38165141 | Mechanical properties of respiratory muscles |
Q30449453 | Mechanical properties of the upper airway |
Q47976663 | Melatonin prevents hyperglycemia in a model of sleep apnea |
Q34340704 | Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes |
Q90524853 | Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk |
Q57050031 | MiRNA expression profiles in healthy OSAHS and OSAHS with arterial hypertension: potential diagnostic and early warning markers |
Q91803429 | MicroRNA expression profile is altered in the upper airway skeletal muscle tissue of patients with obstructive sleep apnea-hypopnea syndrome |
Q47875351 | Morning cortisol levels and glucose metabolism parameters in moderate and severe obstructive sleep apnea patients. |
Q30411852 | Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge |
Q30411856 | Morphine has latent deleterious effects on the ventilatory responses to a hypoxic-hypercapnic challenge |
Q36282468 | Multimodality therapy for sleep apnea syndromes |
Q48420421 | Muscarinic acetylcholine receptors enhance neonatal mouse hypoglossal motoneuron excitability in vitro |
Q37284845 | Neonatal Maternal Separation Augments Carotid Body Response to Hypoxia in Adult Males but Not Female Rats |
Q47600668 | Neonatal maternal separation opposes the facilitatory effect of castration on the respiratory response to hypercapnia of the adult male rat: Evidence for the involvement of the medial amygdala |
Q47996462 | Neonatal stress affects the aging trajectory of female rats on the endocrine, temperature, and ventilatory responses to hypoxia |
Q48182180 | Neonatal stress augments the hypoxic chemoreflex of adult male rats by increasing AMPA receptor-mediated modulation |
Q28078657 | Neural Control of Blood Pressure in Chronic Intermittent Hypoxia |
Q37591858 | Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms |
Q38111288 | Neural control of the upper airway: integrative physiological mechanisms and relevance for sleep disordered breathing |
Q58754382 | Neuroanatomical Basis of State-Dependent Activity of Upper Airway Muscles |
Q38363900 | Neurogenic changes in the upper airway of obstructive sleep apnoea |
Q36382223 | Neurogenic mechanisms underlying the rapid onset of sympathetic responses to intermittent hypoxia. |
Q38111735 | Neuronal control of breathing: sex and stress hormones. |
Q64914170 | Neurotrophic factor BDNF is upregulated in soft palate muscles of snorers and sleep apnea patients. |
Q89635060 | Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan |
Q36189704 | Nonlinear Dynamics Forecasting of Obstructive Sleep Apnea Onsets. |
Q35957627 | Novel Approach to Simulate Sleep Apnea Patients for Evaluating Positive Pressure Therapy Devices |
Q35541483 | NuMoM2b Sleep-Disordered Breathing study: objectives and methods |
Q92692917 | OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions |
Q37961776 | Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. |
Q60624588 | Obesity, obstructive sleep apnea and type 2 diabetes mellitus: Epidemiology and pathophysiologic insights |
Q48034168 | Observation following tonsillectomy may be inadequate due to silent death |
Q37658755 | Obstructive Sleep Apnea and Lipid Abnormalities |
Q34729134 | Obstructive Sleep Apnea and Multiple Anthropometric Indices of General Obesity and Abdominal Obesity among Young Adults. |
Q40160441 | Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in MESA. |
Q38878249 | Obstructive Sleep Apnea and Vascular Diseases. |
Q36764419 | Obstructive Sleep Apnea in Patients with Branch Retinal Vein Occlusion: A Preliminary Study |
Q36368997 | Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis |
Q93032893 | Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease |
Q38736599 | Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota |
Q88301765 | Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism |
Q37530601 | Obstructive sleep apnea and neurocognitive performance: the role of cortisol |
Q64983915 | Obstructive sleep apnea as an independent predictor of postoperative delirium and pain: protocol for an observational study of a surgical cohort. |
Q57788725 | Obstructive sleep apnea in patients surviving acute hypercapnic respiratory failure is best predicted by static hyperinflation |
Q33983903 | Obstructive sleep apnea in pregnancy: reliability of prevalence and prediction estimates |
Q30447694 | Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion |
Q48330682 | Obstructive sleep apnea may increase the risk of stroke in AF patients: Refining the CHADS2 score |
Q43568388 | Obstructive sleep apnea pharmacotherapy: one step closer |
Q36722885 | Obstructive sleep apnea related to rapid-eye-movement or non-rapid-eye-movement sleep: comparison of demographic, anthropometric, and polysomnographic features |
Q38179027 | Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor |
Q33988159 | Obstructive sleep apnea syndrome is associated with deficits in verbal but not visual memory |
Q28084261 | Obstructive sleep apnea, pain, and opioids: is the riddle solved? |
Q47973595 | Obstructive sleep apnoea should be deemed a cardiovascular disease. |
Q89216818 | Obstructive sleep apnoea syndrome |
Q26785989 | Obstructive sleep apnoea syndrome and its management |
Q28081330 | On the cutting edge of obstructive sleep apnoea: where next? |
Q30414026 | Optogenetic stimulation of c1 and retrotrapezoid nucleus neurons causes sleep state-dependent cardiorespiratory stimulation and arousal in rats |
Q39194858 | Oral appliance in sleep apnea treatment: respiratory and clinical effects and long-term adherence |
Q47669203 | Oral appliance treatment outcome can be predicted by continuous positive airway pressure in moderate to severe obstructive sleep apnea |
Q37114229 | Origins of and implementation concepts for upper airway stimulation therapy for obstructive sleep apnea |
Q48221600 | Overnight heart rate variability in patients with obstructive sleep apnoea: a time and frequency domain study. |
Q38695841 | Oxygen sensing by the carotid body: mechanisms and role in adaptation to hypoxia. |
Q37169927 | P2Y1 receptors expressed by C1 neurons determine peripheral chemoreceptor modulation of breathing, sympathetic activity, and blood pressure |
Q64265091 | Palatal anatomy for sleep apnea surgery |
Q47772821 | Palatoglossus coupling in selective upper airway stimulation |
Q27025575 | Pathogenic roles of the carotid body inflammation in sleep apnea |
Q36053044 | Pathological effects of obstructive apneas during the sleep cycle in an animal model of cerebral small vessel disease |
Q38219952 | Pathophysiology of human ventilatory control |
Q37840296 | Patterns of unexpected in-hospital deaths: a root cause analysis |
Q48004029 | Periodic breathing in healthy humans at exercise in hypoxia. |
Q48260732 | Pharyngeal neuropathy in obstructive sleep apnea: where are we going? |
Q30241786 | Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches |
Q48298175 | Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness |
Q30429878 | Photostimulation of Phox2b medullary neurons activates cardiorespiratory function in conscious rats |
Q35882854 | Physiological and pathophysiological interactions between the respiratory central pattern generator and the sympathetic nervous system |
Q26829148 | Physiology in medicine: obstructive sleep apnea pathogenesis and treatment--considerations beyond airway anatomy |
Q36303952 | Piecing together phenotypes of brain injury and dysfunction in obstructive sleep apnea |
Q38908062 | Plasticity in respiratory motor neurons in response to reduced synaptic inputs: A form of homeostatic plasticity in respiratory control? |
Q47840395 | Polysomnography findings in spinocerebellar ataxia type 6. |
Q60921514 | Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry |
Q95924542 | Postictal stertor: Associations with focal and bilateral seizure types |
Q90344503 | Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review |
Q90625006 | Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia |
Q93197937 | Potential Role of mRNAs and LncRNAs in Chronic Intermittent Hypoxia Exposure-Aggravated Atherosclerosis |
Q38264989 | Predictors of successful completion of diagnostic home sleep testing in patients with chronic kidney disease. |
Q37120767 | Preeclampsia and Sleep-Disordered Breathing: A Case-Control Study |
Q89172307 | Preperitoneal Bupivacaine Infiltration Reduces Postoperative Opioid Consumption, Acute Pain, and Chronic Postsurgical Pain After Bariatric Surgery: a Randomized Controlled Trial |
Q33588505 | Prevalence and risk factors of obstructive sleep apnea syndrome in a Saudi Arabian population |
Q98224625 | Prevalence of Obstructive Sleep Apnea in Patients With Diabetic Foot Ulcers |
Q47689125 | Prevalence of sleep apnea and cardiovascular risk factors in patients with hypertension in a day hospital model |
Q47733089 | Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study. |
Q36473686 | Pulmonary C-fiber activation attenuates respiratory-related tongue movements |
Q51702895 | Pulmonary vascular tone is dependent on the central modulation of sympathetic nerve activity following chronic intermittent hypoxia. |
Q35085818 | Purinergic signalling contributes to chemoreception in the retrotrapezoid nucleus but not the nucleus of the solitary tract or medullary raphe |
Q38034108 | Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease |
Q47682307 | RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA AND THE PRESENCE AND SEVERITY OF DIABETIC RETINOPATHY. |
Q33679756 | Rapid-eye-movement sleep-predominant central sleep apnea relieved by positive airway pressure: a case report |
Q35562952 | Rats subjected to chronic-intermittent hypoxia have increased density of noradrenergic terminals in the trigeminal sensory and motor nuclei |
Q48251655 | Re: Effects of leptin and obesity on the upper airway function by Polotsky et al. |
Q52730995 | Reactive oxygen radicals and gaseous transmitters in carotid body activation by intermittent hypoxia. |
Q36770711 | Reduced c-Fos expression in medullary catecholaminergic neurons in rats 20 h after exposure to chronic intermittent hypoxia |
Q28391062 | Reducing health disparities: the role of sleep deficiency and sleep disorders |
Q37479198 | Regional cerebral blood flow alterations in obstructive sleep apnea |
Q39608855 | Regional hypoxic cerebral vasodilation facilitated by diameter changes primarily in anterior versus posterior circulation |
Q37510477 | Regional reductions in sleep electroencephalography power in obstructive sleep apnea: a high-density EEG study |
Q30301264 | Regulation of breathing and autonomic outflows by chemoreceptors |
Q90311366 | Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome |
Q92650087 | Relationship Between Sleep Apnea and Coronary Artery Calcium in Patients With Ischemic Stroke |
Q92857283 | Relationship between sleep and obesity among U.S. and South Korean college students |
Q38019769 | Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes |
Q47676615 | Remote consulting with telemonitoring of continuous positive airway pressure usage data for the routine review of people with obstructive sleep apnoea hypopnoea syndrome: A systematic review. |
Q50334203 | Reproducibility of hypercapnic ventilatory response measurements with steady-state and rebreathing methods. |
Q37811998 | Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management |
Q47657170 | Resolution of Symptomatic Obstructive Sleep Apnea Not Impacted by Preoperative Body Mass Index, Choice of Operation Between Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Surgery, or Severity. |
Q30457547 | Respiratory and sleep disorders in mucopolysaccharidosis |
Q45030495 | Respiratory modulation of human autonomic function on Earth. |
Q47762734 | Resting cerebral blood flow alteration in severe obstructive sleep apnoea: an arterial spin labelling perfusion fMRI study |
Q45751138 | Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease |
Q48886201 | Restructuring of sleep and reversal of REM-induced supraspinal hypotonia of respiratory muscles following bilateral phrenicotomy |
Q90537703 | Risk factors for the development of idiopathic pulmonary fibrosis: A review |
Q37254188 | Risk of obstructive sleep apnea, excessive daytime sleepiness and depressive symptoms in a Nigerian elderly population |
Q39268819 | Role of Carotid Body in Intermittent Hypoxia-Related Hypertension |
Q47781593 | Role of angiotensin-converting enzyme 1 within the median preoptic nucleus following chronic intermittent hypoxia |
Q33976322 | Role of chemoreception in cardiorespiratory acclimatization to, and deacclimatization from, hypoxia |
Q30393764 | Role of nitric oxide-containing factors in the ventilatory and cardiovascular responses elicited by hypoxic challenge in isoflurane-anesthetized rats |
Q35880067 | Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension |
Q47918714 | Roles of interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and treatment in obstructive sleep apnea: a meta-analysis |
Q91257407 | Sagittal Measurement of Tongue Movement During Respiration: Comparison Between Ultrasonography and Magnetic Resonance Imaging |
Q62007536 | Schlafbezogene Atmungsstörungen |
Q89024739 | Sciatic nerve stimulation and its effects on upper airway resistance in the anesthetized rabbit model relevant to sleep apnea |
Q45330173 | Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system |
Q89581132 | Severe desaturations increase PVT-based median reaction time and number of lapses in OSA patients |
Q77790350 | Severe obstructive sleep apnea is associated with alterations in the nasal microbiome and an increase in inflammation |
Q93092764 | Severity of Desaturations Reflects OSA-Related Daytime Sleepiness Better Than AHI |
Q47652448 | Sex differences in sleep apnea and comorbid neurodegenerative diseases. |
Q37631992 | Should the diagnosis and management of OSA move into general practice? |
Q36974940 | Signalment, clinical presentation, concurrent diseases, and diagnostic findings in 28 dogs with dynamic pharyngeal collapse (2008-2013). |
Q59328947 | Silencing of Hypoglossal Motoneurons Leads to Sleep Disordered Breathing in Lean Mice |
Q36443187 | Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver |
Q54936459 | Simulation of the upper airways in patients with obstructive sleep apnea and nasal obstruction: A novel finite element method. |
Q38901960 | Simultaneous recording of ultrasound and polysomnography during natural sleep in patients with obstructive sleep apnea: a pilot study. |
Q42353190 | Sleep Apnea in Familial Dysautonomia: A Reflection of Apnea Pathogenesis |
Q38756440 | Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. |
Q47645255 | Sleep apnea and pesticide exposure in a study of US farmers |
Q37676196 | Sleep apnea and risk of pneumonia: a nationwide population-based study |
Q33943666 | Sleep apnea in fragile X premutation carriers with and without FXTAS. |
Q38754350 | Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility. |
Q48291170 | Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors |
Q39519512 | Sleep apnea is associated with an increased risk of mood disorders: a population-based cohort study |
Q38558161 | Sleep at high altitude: guesses and facts |
Q41443686 | Sleep disordered breathing and the risk of psoriasis among US women. |
Q28596790 | Sleep disordered breathing: is it different for females? |
Q40957500 | Sleep disorders in pregnancy and their association with pregnancy outcomes: a prospective observational study |
Q43123404 | Sleep disorders, public health, and public safety. |
Q39369116 | Sleep disturbance and sleep-disordered breathing in hemodialysis patients |
Q48302890 | Sleep in patients with large pleural effusion: impact of thoracentesis |
Q37103429 | Sleep symptoms, race/ethnicity, and socioeconomic position. |
Q87659769 | Sleep-Disordered Breathing During Congestive Heart Failure: To Intervene or Not to Intervene? |
Q34276124 | Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study |
Q56344132 | Sleep-disordered breathing and electrocardiographic QRS-T angle: The MESA study |
Q37193708 | Sleep-disordered breathing and gestational diabetes mellitus: a meta-analysis of 9,795 participants enrolled in epidemiological observational studies |
Q95261292 | Sleep-disordered breathing in pregnancy: a developmental origin of offspring obesity? |
Q48102128 | Sleep-disordered breathing-related neurocognitive impairment, time to think beyond hypoxia and sleep fragmentation? |
Q37185178 | Sleep-related changes in autonomic control in obstructive sleep apnea: a model-based perspective |
Q63516839 | Sloshing and slamming oscillations in a collapsible channel flow |
Q37219893 | Snoring, daytime sleepiness, and incident cardiovascular disease in the health, aging, and body composition study |
Q33607080 | Specific branches of hypoglossal nerve to genioglossus muscle as a potential target of selective neurostimulation in obstructive sleep apnea: anatomical and morphometric study. |
Q26858790 | State-dependent and reflex drives to the upper airway: basic physiology with clinical implications |
Q34305377 | Sustained hyperoxia stabilizes breathing in healthy individuals during NREM sleep |
Q38863582 | Symptomless Multi-Variable Apnea Prediction Index Assesses Obstructive Sleep Apnea Risk and Adverse Outcomes in Elective Surgery. |
Q92431564 | THE ROLE OF CORTISOL IN NEUROCOGNITIVE PERFORMANCE IN OBSTRUCTIVE SLEEP APNEA PATIENTS |
Q26771548 | Tailored treatment strategies for obstructive sleep apnea |
Q37653173 | Telemedicine-based approach for obstructive sleep apnea management: building evidence. |
Q48121063 | Testosterone potentiates the hypoxic ventilatory response of adult male rats subjected to neonatal stress. |
Q82459833 | Testosterone restores respiratory long term facilitation in old male rats by an aromatase-dependent mechanism |
Q58799135 | The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease |
Q34288892 | The Impact of Obstructive Sleep Apnea on Chronic Kidney Disease |
Q93186026 | The Purinome and the preBötzinger Complex - A Ménage of Unexplored Mechanisms That May Modulate/Shape the Hypoxic Ventilatory Response |
Q33692680 | The Relationship between High Risk for Obstructive Sleep Apnea and General and Central Obesity: Findings from a Sample of Chilean College Students |
Q41665400 | The Role of the Autonomic Nervous System in the Pathophysiology of Obesity. |
Q92670282 | The Sleep-Immune Crosstalk in Health and Disease |
Q39043956 | The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology |
Q36764166 | The Young Everest Study: preliminary report of changes in sleep and cerebral blood flow velocity during slow ascent to altitude in unacclimatised children. |
Q36639762 | The association between atrial fibrillation and stroke in patients with obstructive sleep apnea: a population-based case-control study |
Q36287773 | The association of kidney function with repetitive breath-hold diving activities of female divers from Korea, Haenyeo |
Q34992979 | The correlation between red blood cell distribution width levels with the severity of obstructive sleep apnea and carotid intima media thickness. |
Q47811332 | The effect of CPAP treatment on venous lactate and arterial blood gas among obstructive sleep apnea syndrome patients |
Q36422672 | The effect of leptin replacement on sleep-disordered breathing in the leptin-deficient ob/ob mouse |
Q35888424 | The effect of tongue exercise on serotonergic input to the hypoglossal nucleus in young and old rats |
Q30428971 | The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions. |
Q34132243 | The hypoxic ventilatory response and ventilatory long-term facilitation are altered by time of day and repeated daily exposure to intermittent hypoxia |
Q36531006 | The impact of arousal state, sex, and sleep apnea on the magnitude of progressive augmentation and ventilatory long-term facilitation |
Q38077649 | The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials |
Q36089133 | The importance of obstructive sleep apnoea and hypopnea pathophysiology for customized therapy |
Q47798673 | The mechanisms underlying the production of discontinuous gas exchange cycles in insects |
Q38227865 | The nucleus of the solitary tract and the coordination of respiratory and sympathetic activities |
Q41970894 | The ongoing need for good physiological investigation: obstructive sleep apnea in HIV patients as a paradigm |
Q48190404 | The predictive value of Muller's maneuvre for CPAP titration in OSAHS patients |
Q47799287 | The rat cerebral vasculature exhibits time-of-day-dependent oscillations in circadian clock genes and vascular function that are attenuated following obstructive sleep apnea |
Q37446892 | The relation between sleep and weight in a suburban sleep center: observations and speculations on apnea and weight |
Q47642170 | The role of hypoxia-inducible factors in carotid body (patho) physiology. |
Q55064054 | The role of loop gain in predicting upper airway surgical outcomes-what do we know? |
Q47122578 | The role of sleepiness on arterial stiffness improvement after CPAP therapy in males with obstructive sleep apnea: a prospective cohort study |
Q38722814 | The role of telemedicine in obstructive sleep apnea management |
Q55283429 | The use of drug-induced sleep endoscopy in England and Belgium. |
Q43626222 | The use of dual-energy X-ray absorptiometry in the evaluation of obesity in women with obstructive sleep apnea-hypopnea syndrome. |
Q37599616 | Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults |
Q90287454 | Three-dimensional volumetric magnetic resonance imaging (MRI) analysis of the soft palate and nasopharynx in brachycephalic and non-brachycephalic dog breeds |
Q48030804 | Time of day affects chemoreflex sensitivity and the carbon dioxide reserve during NREM sleep in participants with sleep apnea |
Q47954720 | Time of day affects the frequency and duration of breathing events and the critical closing pressure during NREM sleep in participants with sleep apnea |
Q51645835 | Time-varying signal analysis to detect high-altitude periodic breathing in climbers ascending to extreme altitude. |
Q45323315 | Toll-like receptor activity in patients with obstructive sleep apnea |
Q38039502 | Tongue anatomy and physiology, the scientific basis for a novel targeted neurostimulation system designed for the treatment of obstructive sleep apnea |
Q36004147 | Tonic and phasic drive to medullary respiratory neurons during periodic breathing. |
Q36752050 | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea |
Q37637184 | Treatment of obstructive sleep apnea alters cancer-associated transcriptional signatures in circulating leukocytes. |
Q38302944 | Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia |
Q30360424 | Ultrasonographic Detection of Airway Obstruction in a Model of Obstructive Sleep Apnea. |
Q98385778 | Ultrasonographic Measurement of Pharyngeal-Airway Dimension and Its Relationship with Obesity and Sleep-Disordered Breathing |
Q35597819 | Uncoupling protein-2 mRNA expression in mice subjected to intermittent hypoxia |
Q89287564 | Understanding Pathophysiological Concepts Leading to Obstructive Apnea |
Q98772430 | Updates on management of pediatric obstructive sleep apnea |
Q35615468 | Upper Airway Stimulation for Obstructive Sleep Apnea: Past, Present, and Future |
Q58121715 | Ventilatory and Autonomic Regulation in Sleep Apnea Syndrome: A Potential Protective Role for Erythropoietin? |
Q42120765 | Ventilatory oscillations at exercise: effects of hyperoxia, hypercapnia, and acetazolamide |
Q49106586 | Ventral hippocampus modulates bradycardic response to peripheral chemoreflex activation in awake rats |
Q37247926 | Vitamin D Concentrations and Obstructive Sleep Apnea in a Multicenter Cohort of Older Males |
Q48036106 | WITHDRAWN: Sleep quality changes in chronically depressed patients treated with mindfulness-based cognitive therapy or cognitive behavioral analysis system for psychotherapy: a pilot study |
Q64298382 | Working Time Society consensus statements: Evidence-based effects of shift work on physical and mental health |
Q45344902 | Worsening of central sleep apnea at high altitude--a role for cerebrovascular function |
Q36686466 | Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea. |
Q87139228 | [Sleep apnea and heart failure] |
Q35104879 | eAMI: a qualitative quantification of periodic breathing based on amplitude of oscillations |
Q34414609 | β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats |
Search more.